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ABSTRACT
There is an emerging market for functional oligosaccharides for use in foods. Currently,
technology for the production of oligosaccharides is limited to extraction from plant sources,
acid or enzymatic hydrolysis of polysaccharides or synthesis by transglycosylation reactions.
Oligosaccharides also can be produced using a Leuconostoc fermentation and restricting the
polymer size by the addition of maltose. Maltose limits the dextransucrase reaction, yielding
high concentrations of α-glucooligosaccharides. Branched oligomers produced by this
process were found to be readily catabolized by bifidobacteria and lactobacillus but were not
readily utilized by either Salmonella sp., or E. coli, pointing toward their use in intestinal
microflora modification. Branched α-glucooligosaccharides were non-competitive inhibitors
of α-glucosidase (maltase), an enzyme required for starch or maltodextrin utilization.

viii

INTRODUCTION
Use of functional food products, especially those containing live cultures of Bifidobacterium
and Lactobacillus, called probiotics, has increased (Roberfroid, 2000). These bacteria reside
naturally in the large intestine. Although the mechanism of action is not fully understood,
the available evidence indicates ingestion of probiotic bacteria may actually improve several
of the host’s physiological processes. These include the alleviation of lactose intolerance,
immune enhancement, and a reduction in mutagenic enzymes such as β-glucuronidase,
nitroreductase, and choloylglycine hydrolase (Collins and Gibson, 1999; Roos and Katan,
2000). To be effective, dietary probiotics must reach the large intestine. Barriers in the
human body, which include acidic pH in the stomach, degradative enzymes and bile in the
small intestine, often prohibit effective ingestion of probiotics. Researchers have attempted
to isolate bacterial strains resistant to bile and acidic conditions (Chung et al., 1999; Kaplan
and Hutkins, 2000) and have also tried to develop microencapsulation technology that would
protect these bacteria on their way to a target location (Crittenden et al., 2001).
It is believed that the ability of these probiotics to catabolize oligosaccharides (two to
ten monosaccharide units linked with glycosidic bonds) is a key factor in their bestowing
beneficial health effects. Certain carbohydrates, called prebiotics, can escape metabolism
and adsorption in the small intestine and ultimately influence the composition of microflora
in the large intestine (Loo et al., 1999). Prebiotics are generally non-digestible by humans.
Oligosaccharides are used widely in foods such as soft drinks, cookies, cereals, candies, and
dairy products. Other applications for oligosaccharides such as an anti-cariogenic agent
(Ooshima et al., 1983) or a low sweetness humectant (Yoo et al., 1995) have been explored.
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Antibiotic resistance among known pathogens such as Salmonella and E. coli is
expanding due to the wide use of these compounds in areas ranging from medicine to animal
feed. The pressure to remove antibiotics from animal feeds has left a need for safe
alternatives that can reduce levels of these bacteria in animals (Hileman, 2001; Hofacre et al.,
2000). Selected fructooligosaccharides and glucooligosaccharides have shown potential as
alternatives to antibiotics (Monsan and Paul, 1995). Those oligosaccharides with the greatest
antibacterial effects are either fructans or branched glucans (Anonymous, 1999; Loo et al.,
1999; Valette et al., 1993).
Prebiotic oligosaccharides are currently produced either by extraction from plant
sources, acid or enzymatic hydrolysis of polysaccharides or enzymatic synthesis by
transglycosylation reactions (Chesson, 1993; Morgan et al., 1992). Glucooligosaccharides
can be produced by restricting polymer size during the fermentation process (Koepsell et al.,
1952). Dextransucrase (EC 2.4.1.5), an enzyme usually produced by species of Leuconostoc
and Streptococcus, catalyzes the synthesis of high molecular weight glucans (dextrans).
In the presence of sucrose, dextransucrase produces a linear backbone of Dglucopyranosyl units, linked α-1,6 that can have variable amounts of α-1,2, α-1,3, or α-1,4branched side chains. The actual degree of branching depends on the specific strain of
microorganism (Robyt, 1986). When an efficient chain ending acceptor, such as maltose or
isomaltose, is present in high concentration, dextransucrase will catalyze the synthesis of αglucooligosaccharides (Koepsell et al., 1952; Robyt and Eklund, 1983). This process applied
to a L. mesenteroides ATCC 13146 fermentation produces branched glucooligosaccharides
that can function as prebiotics.
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The goals of the present research are to develop an industrial production method for
oligosaccharides using a L. mesenteroides ATCC 13146 fermentation by acceptor reaction
and to show potential of these oligosaccharides as prebiotics.
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LITERATURE REVIEW
1. Prospective for Functional Foods
The term functional foods was first introduced in Japan in the mid- 1980s and refers either
to processed foods containing ingredients that aid specific bodily functions in addition to
being nutritious, or food ingredients that provide health benefits beyond that expected from
its components (Hasler 1996, Table 1). Physiologically functional foods have been
developed in Japan during the past ten years. These foods are now known as Foods for
Specified Health Use (FOSHU) and are regulated by the Japanese government, bearing its
seal of approval. About 100 such products are licensed in Japan as FOSHU foods (Hasler
1998). Their market in Japan reached $4.5 billion in 1995 and the annual growth rate was
8.0%. In the United States, functional foods are not categorized by law, though the Institute
of Medicine’s Food and Nutrition Board (IOM/NAS, 1994) gave a definition to functional
foods as “any food or food ingredient that may provide a health benefit beyond the
traditional nutrients it contains.” According to an estimation by Decision Resources, Inc.
(Waltham, 1998), the current US market for functional foods is calculated at $28.9 billion. It
is also one of the fastest growing segments of the food industry (Tomomatsu, 1994). A
number of factors have contributed to the rapid development of functional foods. They
include scientific advances supporting the vital role of diet in overall health and well-being,
consumer demand, the increased role of food and food ingredients for self-medication and
disease prevention, a changing regulatory environment, and technical advances in the food
industry, to name a few (Hasler, 1996).
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Table 1. Several foods known as functional foods
Source Basis
Plants

Foods / ingredients

Proposed Health claims

Oats / soluble fiber β-glucan

Reductions in total and low density lipoprotein (LDL)
cholesterol

Soy / isoflavons

Increasing bone minerals and density

Protease inhibitors

Cholesterol-lowing effect

Phytic acid

Reduction of risk of estrogen-dependent cancer

Phytosterols, Saponins
Flaxseed / ω-3 fatty acids

Reduction of risk of estrogen-dependent cancer
Reductions in total and low density lipoprotein

Tomatoes / lycopene

Reduction of risk of cancer

Garlic / sulfur- containing

Chemo-prevention of cancer

compounds

Antibiotic, Antihypertensive
Cholesterol-lowering effects

Broccoli and other

Reduction of the risk breast cancer

Cruciferous Vegetables /
isothiocyanates, indoles
Citrus Fruits / limonoids

Anticancer activity

Cranberry / unidentified

Reduction of urinary tract infections

polymeric compounds
Tea / catechins

Chemo-prevention of cancer
Reduction of cardiovascular disease

Wine and Grapes /

Reduction of cardiovascular disease

phenolics
Animals

Fish / ω-3 fatty acids

Reduction of cardiovascular disease

Dairy Products / lactic acid

Improving intestinal microbial balance

bacteria

Source of calcium and an essential nutrients

Oligosaccharides

Reduction of colon cancer

Beef /

Suppressing forestomach tumors in mice cell

conjugated linoleic acid

Adapted from Hasler 1998
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2. Probiotic and Prebiotics as Functional Foods
One of the more sophisticated approaches to customizing health benefits is the use of
probiotics. Probiotic(s), derived from the Greek words meaning “for life” (Lyons, 1987), are
defined as “live microorganisms that confer a health effect on the host when consumed in
adequate amounts” (Guarner and Schaafsma, 1998). Bifidobacterium and Lactobacillus
species have been the focus of probiotic interest as large populations of these bacteria in the
intestinal tract are generally considered indicative of a healthy microbiota (Ballongue, 1998;
Freter, 1992; Mikelsaar et al., 1998). Ele Metchnikoff was the first to observe the health
benefit of probiotics. He suggested that the long life of Bulgarian peasants resulted from
their consumption of a fermented milk product. The Lactobacilli they consumed beneficially
altered the microflora of the colon and decreased raw toxic effects of other colonic
microorganisms. His concept has become widely accepted and is driving today’s research,
product development, and marketing of functional foods. Bacteria are being included in
increasing numbers as functional ingredients, particularly in dairy products such as yogurts
and fermented milks, as the evidence accumulates that they confer beneficial effects on
human health (Mattila-Sandholm et al., 1999; Crittenden et al., 2001).
Most research on probiotics in vitro has been done using only a few bacterial strains or
combinations of strains at different doses (Table 2). Animal and human studies have shown
probiotics can produce beneficial effects on human health. According to recent reviews
(Roberfroid, 2000; Rolfe, 2000), probiotics improve bodily functions in the following
manner :
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Table 2. Postulated beneficial health effects of probiotics and prebiotics
Functional effects

References
Probiotics

Prebiotics

Alleviation of lactose

Kim and Gillard 1983,

Not available

intolerance

Pettoello Mantovani et al. 1989,
Sanders 1993, Marteau et al. 1997,
Goldin 1998

Stimulation of gut

Gill et al. 2000, Kato et al. 1999,

immunity

Perdigon et al. 1995, Marteau and

Not available

Rambaud 1993, Schiffirin et al.
1995, Famularo et al. 1997
Prevention of pathogen

Bernet et al. 1993, Hudault et al.

Gibson and Roberfroid 1995,

colonization

1997, Pascual et al. 1999

Roberfroid et al. 1998, Loo et
al. 1999. (Strong)

Lowering of serum

Fukushima and Nakano 1996,

Kok et al. 1998, Roberfroid and

cholesterol

Mohan et al. 1995,

Delzenne 1998, Davidson et al.

Mohan et al. 1996,

1998 (Preliminary)

Reduction in

Adawi et al. 1997,

Not available

inflammatory reactions

Perdigon et al. 1991

Hypolipidema

Not available

Jackson et al. 1999, Loo et al.
1999,

Canzi

Delzenne

et

and

al.,

1995,

Kok

1999

(Promising)
Increased production of

Not available

Campbell et al. 1997, Djouzi

short-chain fatty acids

and Andrieux 1997

(Table 2. Con’d)
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Modification of the gut flora

Fuller and Gibson 1997, Hofacre et

Gibson

and

Wang

1994a,

al. 1998,

Kleessen et al. 1997, Kruse et al.

Hosono et al. 1997

1999, McBain and Macfarlane

(Preliminary )

1997, Wang and Gibson 1993,
Gibson et al. 1995, Gibson and
Roberfroid 1995, Roberfroid et
al. 1998, Loo et al. 1999
(Strong)

Disease risk reduction

Probiotics

Prebiotics

Prevention of cancer

McIntosh et al. 1999, Pool-Zobel et

Reddy et al. 1997, Rowland et

al. 1993, Singh et al. 1997

al. 1998

Majamaa and Isolauri 1997, Pelto et

Not available

Reduction of food-allergies

al. 1998,
Improvement of the

Not available

Coudray et al. 1997, Delzenne et

bioavailability of minerals

al. 1995, Ohta et al.

1995,

Heuvel et al. 1999
(Promising)
Diarrhea

Gibson et al. 1995, Corthier 1997,

Not available

Isolauri et al. 1991, Saavedra et al.
1994. (Promising)
Constipation

Not available

Reddy 1998, Gibson et al. 1995
(Promising)

Adapted from Simmering and Blaut 2001, and Rolfe 2000
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1) Alleviation of lactose intolerance
This effect may be due to either of two probable mechanisms, either the reduction of lactose
in the dairy diet through fermentation with lactase-positive strains or the growth of a
probiotic in the gastrointestinal tract which releases lactase.
2) Decrease of diarrhea
Diarrhea is a symptom that is closely related to the health of the gastro-intestinal tract. Many
studies have shown positive effects of probiotics on antibiotic-induced diarrhea, traveler’s
diarrhea, HIV/AIDS diarrhea, and rotavirus diarrhea.
3) Immune enhancement
Animal studies showed that the ingestion of probiotics stimulated intestinal IgA and the
production of cytokines by blood mononuclear cells. Erickson and Hubbard (2000) indicated
that a probiotic treatment demonstrated putative effects on modulation of immune function
such as enhancing phagocytosis; the mechanisms of which are still unclear.
4) Decreased carcinogenesis
Accumulating evidence shows that numerous intestinal flora influence carcinogenesis by
production of enzymes that transform precarcinogens into carcinogens. Consumption of
probiotics has reduced levels of fecal microbial enzymes such as β-glucuronidase, βglucosidase, nitroreductase and urease, all related to carcinogenesis.
Numerous

other

positive

effects

have

been

reported,

including

a

hypocholesterolemic effect, decreased inflammatory bowel disease and decreased incidence
of colon cancer, etc. Generally, probiotic treatments show positive effects; however, there is
still no convincing evidence available to support specific health claims for any particular
strain of probiotics. (O’Sullivan and Kullen, 1998).
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The proposed mechanisms of action of probiotics range from 1) production of
inhibitory substances, such as organic acids, hydrogen peroxide and bacteriocins 2) blocking
of adhesion sites on epithelial surfaces, along with volatile fatty acid production, resulting in
competitive inhibition (Rolfe, 2000; Conway et al., 1987; Goldin et al., 1992; Kleeman and
Klaenhammer, 1982; Starvic, 1987) 3) competition for nutrients (probiotic may utilize
nutrients otherwise consumed by pathogenic microorganism) 4) degradation of toxin
receptor (Rolfe, 2000; Castagliuolo et al., 1996 and 1999) to 5) stimulation of immunity
(Rolfe, 2000; Fukushima et al., 1998; Kaila et al., 1992; Link-Amster et al., 1994; Malin et
al., 1996; Perdigon et al., 1986; Pouwels et al., 1996; Saavedra et al., 1994)
3. Oligosaccharides as Prebiotics
To be effective, probiotics must reach the large intestine. However, there are barriers in the
human body to delivery of the intestinal live bacteria via foods, primarily acidic pH in the
stomach and degradative enzymes and bile in the small intestine. These barriers lower the
delivery rate of live probiotic bacteria to the large intestine. Researchers have tried to isolate
strains resistant to bile and acidic conditions (Kociubinski et al., 1999; Chung et al., 1999)
or to develop protective microencapsulation technology that involves encasing bacteria into
inert carriers with limited success (Forssell et al., 1999).
An alternative to direct ingestion of live bacteria into the colon through dietary
supplementation is to increase populations of natural Bifidobacteria and Lactobacilli in the
intestinal microbiota through the use of prebiotics. Prebiotics are nondigestible dietary
components that pass through the digestive tract to the colon and selectively stimulate
proliferation and/or activity of desired populations of bacteria in situ (Gibson and
Roberfroid, 1995; Loo et al., 1999). Due to a potential synergy between probiotics and
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prebiotics, foods containing a combination of these ingredients are often referred to as
synbiotics (Collins and Gibson, 1999; Gibson and Roberfroid, 1995). The probiotics
identified thus far are nondigestible carbohydrates, including lactulose, inulin, and a range of
oligosaccharides (Crittenden, 1999; Crittenden et al., 2001).
A number of different oligosaccharides have shown stimulation of growth of
probiotic strains and are now widely used as prebiotics. The term oligosaccharide is applied
to short saccharide polymers, joined by glycosidic bonds, ranging from two to ten
monosaccharide units. Many of these oligosaccharides were originally used as sweeteners in
foods. They are now regarded as “soluble fiber”. They have a common property of being
resistant to attack by human and animal digestive enzymes and are not directly absorbed by
the host. For this reason, they are considered to be low calorie materials. Basically,
oligosaccharides are produced by several methods (Morgan et al., 1992; Chesson, 1993;
Monsan et al., 1995)
These include:
- extraction from plant sources (e.g. fructooligosaccharides, α-galactooligosaccharides)
- controlled enzymatic hydrolysis of polysaccharides (e.g fructooligosaccharides,
xylooligosaccharides)
-

enzymatic

synthesis

(e.g.

fructooligosaccharides,

α-glucooligosaccharides,

β-

glucooligosaccharides, β-galactooligosaccharides)
3.1 Types
• Fructooligosaccharides (FOS)
These oligosaccharides have attracted serious commercial interest as prebiotics. They are
composed of a D-glucopyranose unit at the non-reducing end (G) linked α-1,2 to two or
11

more β-2,1-linked fructosyl units (F). This group includes 1-kestose (GF2), nystose (GF3),
and 1F-fructofuranosyl nystose (GF4). These compounds marketed commercially as
Raftilose and Nutraflora in the United States, are produced from three different sources.
They can be extracted from plants. Onions (Shiomi, 1978) and asparagus (Shiomi et al.,
1976) contain particularly high amounts of fructooligosaccharides compared to other plant
sources (Fishbein et al., 1988). They can be produced by controlled (limited) enzymatic
hydrolysis of inulin polymers from chicory or Jerusalem artichokes (Heinz and Vogel,
1991). Raffineries Tirlemontoises in Belgium uses a production process based on this
method. The third route is by enzymatic synthesis from sucrose using a fructosyltransferase
(EC 2.4.1.100) from Aspergillus niger or Aureobasidium pullulans (Hidaka et al., 1988;
Hidaka and Hirayama, 1991). The synthesis occurs according to the following reaction:
fructosyltransferase
n G-F

G-Fn + (n-1)G

(sucrose)

(FOS)

(glucose)

The FOS products Neosugar® and Nutraflora are produced this way. These products
generally contain a proportion of glucose and sucrose that can be used by most other
bacteria. To obtain products with higher FOS content, chromatography is used to separate
glucose and sucrose from the reaction mixture. FOS are self-affirmed by their manufacturers
as GRAS (generally recognized as safe) (Speigel et al., 1994) and have been added to infant
formulas, yogurt and other food products and food supplements (Kaplan and Hutkins, 2000).
• α-Isomaltooligosaccharides
α-Isomaltooligosaccharides contain α-1,6 bonds and are generally obtained from starch
hydrolysates (maltose and maltodextrins) through the action of the α-transglucosidase (EC
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2.4.1.24) from Aspergillus sp. (Roper and Koch, 1988). Maltose and maltodextrins can act
as both glucosyl donor and acceptor to this enzyme. Hayashibara Corp. in Japan developed
this transglucosylation reaction to an industrial process (Yoneyama et al., 1992).
An alternative method for producing isomaltooligosaccharides is by α-amylase (EC
3.2.1.3) and α-glucosidase, combined with a pullulanase (EC 3.2.1.41). This process was
developed by the Showa Sangyo Co., (Yasuda et al., 1986). Isomaltooligosaccharide
production from starch, which is a cheaper raw material than sucrose, is by the hydrolysis of
starch by α-amylase and pullulanase and then transglucosylation of the glucose moiety of
the maltose by α-glucosidase to synthesize α-glucooligosaccharides, linked mainly α-1,6 in
concentrated carbohydrate solutions. Isomaltooligosaccharides can also be obtained from
transglucosylation reactions using a neopullulanase (EC 3.2.1.135) from Bacillus
stearothermophillus, which has been modified by site-directed mutagenesis (Kuriki et al.,
1993). There are some disadvantages in this production method. All these processes are
multi-step requiring gelatination, liquefaction, saccharification, and purification and there
are always some mono-, and/or disaccharides in the final product (Yoo, 1997).
Branched α-isomaltooligosaccharides can also be produced by an acceptor-reaction
catalyzed with dextransucrase (EC 2.4.1.5). The dextransucrase from L. mesenteroides
NRRL B-1299 can produce α-glucooligosaccharides (GOS) containing one or more Dglucopyranosyl branch units linked via α-1,2 glycosidic bonds if maltose supplied as an
acceptor (Paul et al. 1992, Remaud-Simeon et al. 1994).
• α-Galactooligosaccharides
α-Galactosyl derivatives of sucrose are present in many legume seeds. Mono-, di-, and tri-αgalactosylsucrose, known respectively as raffinose, stachyose, and verbascose, are produced
13

by extraction from plants, particularly soybeans (Minami et al., 1983). These
oligosaccharides are known to be, in part, responsible for the flatulence and diarrhea that
follows consumption of beans, because of the absence of an α-galactosidase in the
gastrointestinal tracts of humans and animals.
• Others
A variety of β-glycooligosaccharides can be obtained by enzymatic methods (Fujii and
Komoto, 1991), but these are not available in sufficient quantities or at a sufficiently low
cost to allow their use as additives in foods. Laboratory studies have shown that they are as
resistant to the action of host digestive enzymes as the previously described
oligosaccharides. β-Glucooligosaccharides are obtained when highly concentrated glucose
solutions (70%, w/w) are treated with β-glucosidase (EC 3.2.1.21) (Ajisaka et al., 1987).
The reaction produces a mixture of di- and trisaccharides containing mainly β-1,6
(gentiobiose, gentiotriose) and β-1,4 (cellobiose, cellotriose) glycosidic linkages.
Transgalactosylation

of

lactose

by

β-galactosidase

(EC

3.2.1.23)

produces

β-

galactooligosaccharides. The yield depends on the enzyme-producing microbial source and
on the lactose concentration (Mozaffar et al., 1984; Prakash et al., 1987). βXylooligosaccharides can be produced by enzymatic hydrolysis of plant xylans (Morgan et
al., 1992). They can also be found naturally in bamboo shoots, which are eaten in Asia
(Imaizumi et al., 1991). The efficiency of action of endoxylanases (EC 3.2.1.8) is influenced
by the presence of arabinofuranosyl side chains in the xylan polymer (Kormelink et al.,
1992). Interest in the use of xylanases and related enzymes by the pulp, paper and feed
industries is increasing the availability of this enzyme. (Monsan et al., 1995). Cyclomaltooligosaccharides (cyclodextrins, CDs) are composed of glucose units linked by α-1,4
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linkage in a ring structure. Branched CDs in which the maltose or glucose molecules are
linked by α-1, 6 linkages to CDs were produced for the purpose of increasing the solubility
of CDs. Cyclomalto- oligosaccharides have been used as complexing agents for the
stabilization of oily unstable substances and for modifying the physical properties of
insoluble and volatile materials such as flavors because of their ability to form inclusion
complexes (Kobayashi et al., 1989).
3.2 Beneficial Effects of Oligosaccharides
Ingested oligosaccharides (prebiotics) are able to reach the colon. It has been
proposed that these oligosaccharides are preferentially utilized by Lactobacilli and
bifidobacterial species (Kaplan and Hutkins, 2000). This would increase the intestinal
production of lactic acid and short-chain fatty acids (SCFA), resulting in lower pH in the
large intestine that may help prevent the establishment of undesirable pathogenic organisms
such as Salmonella (Juven et al., 1991). The oligosaccharides may also interact with
carbohydrate receptors present on the surface of either microbial or epithelial cells, affecting
cell adhesion and immunomodulation. (Howard et al., 1995; Naughton et al., 2001)
Fructooligosaccharides and some branched glucooligosaccharides are not digested in
the human small intestine, but can be fermented by certain microorganisms found in human
and livestock intestines, especially by the Bifidobacterium sp. (Tomomatsu, 1994). There are
numerous reports regarding stimulating effects of oligosaccharides on the growth of
probiotic strains. Nagendra et al. (1995) reported that infants fed with a control formula
without lactose had coliforms as the predominant flora and those fed with lactose-containing
formula had bifidobacteria as the predominant flora. Gibson and Wang (1994a) found that
the growth rate of seven of the eight bifidobacterium species they tested were higher on
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fructooligosaccharides than on glucose, the only exception being B. bifidum. In a study
using a simulated human intestinal microbial ecosystem reactor (Molly et al., 1996), called
SHIME, consisting of six closed vessels with a milk containing L. acidophilus and
fructooligosaccharide (FOS), the FOS stimulated bifidobacteria growth. Gmeiner et al.
(2000) reported the consumption of a mixture of L. acidophilus with FOS increased the
population of Bifidobacteria. They also observed increases in amounts of volatile fatty acids,
especially butyric and propionic acids.
In glucooligosaccharide (GOS) studies, Flickinger et al. (2000) studied in vitro
fermentation characteristics using human fecal material, as well as the small intestinal
digestibility and the effects on fecal microbial populations in dogs, with a GOS containing
α-1,2, α-1,4 and α-1,6 linkages, FOS, and others. In in vitro tests, GOS and FOS produced
short chain fatty acids in human fecal material more rapidly than the other substrates, such
as gum arabic, guar gum and guar hydrolysate. GOS appeared to be indigestible in the small
intestine, while supplying a carbon source for bacterial fermentations in the large intestine of
cannulated dogs. When the viable count of B. infantis and B. longum, and changes in pH of
1.0% of various carbohydrates supplemented soymilk were monitored, B. longum showed a
significantly (P<0.05) higher count on a crude isomaltooligosaccharide (75%) supplemented
soymilk than in the control (soymilk without the added supplement) at the end of
fermentation (Chou et al.,2000). In another study, Valette et al. (1993) showed that GOS
was only 20% digested by germfree rats. Dietary isomaltooligosaccharides (13.5g/day for 14
days), another type of GOS, are reported to increase fecal bifidobacteria levels (P<0.05) in
healthy adult males (Kohmoto et al., 1988). Djouzi et al. (1995) investigated the ability of
several human gut bacteria to break the α-1,2 and α-1,6 glycosidic linkages in GOS, in vitro,
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in substrate utilization tests. Branched oligomers were resistant to both gastrointestinal
enzymes and utilization by pathogenic microorganisms. They also reported α-1,2 glucosidic
bonds were more resistant than α-1,6 linkages in kinetic studies on glucooligosaccharide
hydrolysis in pH-regulated fermentations. Bifidobacterium utilizes GOS. Bifidobacteria
concentrations also increased when GOS was added to the diet of cannulated dogs
(Flickinger et al., 2000). Ingestion of either fructooligosaccharides, or branched
oligosaccharides, increased the populations of indigenous bifidobacteria in the colon. As the
result of higher populations of these bacteria, the pH of digestive tract was lowered and the
growth of putrefactive bacteria such as Escherichia, Salmonella, Clostridia was suppressed
(Tomomatsu, 1994).
In addition to its role as a source for increasing probiotic bacteria population,
oligosaccharides are used in processed foods because of other properties. For example,
branched oligosaccharides are milder and softer in taste (Yoo et al., 1995) and have
relatively low viscosity and water activity compared to sucrose. Their low water activity
makes them effective in controlling microbial contamination in processed foods (Yoo et al.,
1995). The xylosylfructosides inhibit the sucrose-splitting activity of glucosyltransferases of
Streptococcus mutans, one of the oral microorganisms implicated in plaque formation (Gore
et al., 1988). Others such as maltooligosaccharides, isomaltulose, and trehalose act as
alternative acceptors for glucosyl transfer reactions from sucrose reducing formation of
insoluble glucans. This makes these oligosaccharides anti-cariogenic. With increasing health
consciousness of consumers, functional properties such as low calories, anti-cariogenecity,
and bifidobacteria growth-promoting factor has expanded the usage of these polysugars
(McKellar and Modler, 1989; Oku et al., 1984; Pszczola, 1988; Spiegel et al., 1994).
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4. Enzyme and Mechanism of Synthesis of α-Glucooligosaccharides
4.1 Glucansucrases (Dextransucrases)
Glucansucrases have been extensively studied because of their role in the production of
dextran and its role in the cariogenic process. Glucansucrases (EC 2.4.5.1), usually
extracellular but in some cases are cell-associated, are mainly produced by soil bacteria.
Those produced by Leuconostoc sp. are called dextransucrase and Streptococcus sp. and
other lactic bacteria, Lactococci, are called glucosyltransferases (Sidebotham, 1974).
Streptococcal glucansucrases synthesize primarily α-1,3 rich polysaccharides. Leuconostoc
glucansucrases produce α-1,6 rich polysaccharides. Genes coding for glucansucrasesproducing branched glucans through α-1,2 or α-1,4 glucosidic bond or synthesizing alternan,
a glucan that has an alternating sequence of α-1,6 and α-1,3 linkage having approximately
50% of α-1,6 and 50% of α-1,3 linkages, have not been isolated.
Glucansucrases catalyze the synthesis of high molecular weight D-glucose polymers
from sucrose. In the presence of efficient acceptors, they may catalyze the synthesis of low
molecular weight oligosaccharides (Koepsell et al., 1952). Glucosidic bond synthesis occurs
without the mediation of nucleotide activated sugars and cofactors are not necessary.
Glucansucrases were first identified more than a half century ago. The first glucansucrase
gene was cloned in the late 1980’s. However, the mechanism of glucansucrase action is still
incompletely understood. The cloning of glucansucrase genes has allowed, in addition to
structure-function relationship studies, the identification of important amino acid residues in
these enzymes (Monchois et al., 1999b).
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4.1.1 Structure and Function
More than 30 genes encoding sucrose GTF (also named glucansucrase) have now been
identified. (For individual gene reference, see Remaud-Simeon et al., 2000, Monchois et al.,
1999b). In spite of the importance of defining the three-dimensional structure of an enzyme,
the

crystallization

of

Leuconostoc

and

Streptococci

glucansucrases

still

defies

crystallographers, probably because of the large size, an avg. of 160kDa (between 155 to
200 kDa) and the flexibility of these proteins. Biochemical studies, sequence alignment
analysis, hydrophobic cluster analysis and structural predictions have revealed that sucrose
GTF shares many mechanistic and structural features with glycoside hydrolases and
particularly with α-amylase, cyclodextrin glucanotransferase and pullulanase, which on the
basis of sequence alignment, have been shown to belong to family13 (Henrissat and Bairoch,
1996). These proteins contain four distinct regions: a signal peptide, a variable region and an
N-terminal catalytic domain followed by a C-terminal glucan binding domain (GBD)
(Ferretti et al., 1987; Simpson et al., 1995; Russell, 1990; Giffard et al., 1993; Vickermann
et al., 1997)
The schematic structure of glucansucrase is shown in figure 1.
• 1st region: N-terminal end (signal peptide region)
This region is typical of the signal peptide region of Gram-positive bacteria. All the GTFs,
except the glucansucrase encoding gene (DSR-A) from L. mesenteroides NRRL B-1299
have, at the N-terminal end, a signal peptide region of 32 to 38 amino acids. This region is
highly conserved, sharing more than 40 - 50% identical or functionally equivalent residues.
This may indicate that the glucansucrases of different species have similar secretion
pathways. (Monchois et al., 1996)
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Signal
Peptide
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(140261 aa)
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N-terminal catalytic
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(900 - 1000 aa)
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(500 aa)

Cterminal

1600
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Figure 1. General schematic diagram of a glucansucrase. (V.R., Variable Region)
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• 2nd region: Variable region
A variable region of 140 to 261 amino acids follows the signal peptide region. The amino
acid sequence of this region has not been extensively investigated. It has been suggested that
because of its high variability this region could be a tracer specific for each GTF (Banas et
al., 1994). It may not have an important role in the protein because the DSR-A, isolated
from L. mesenteroides NRRL B-1299 does not possess this variable region (Monchois et al.,
1999a). The significance of this variable region remains unknown.
• 3rd region: N-catalytic domain
The region immediately following the variable region is a highly conserved region of about
900 -1000 amino acids, named the N-catalytic domain because it contains the essential
aspartic acid involved in the glucosyl-enzyme intermediate (Mooser et al., 1991; Kato et al.,
1992). Further investigations are needed to confirm the functional or structural role of these
residues and to demonstrate how they may function differently depending on the specificity
of the glucansucrase.
• 4th region: C-terminal glucan binding domain (GBD)
At the carboxyl terminal end, glucansucrases from L. mesenteroides or Streptococcus
species strains possess a GBD of about 500 amino acids (Ferretti et al., 1987; Abo et al.,
1991; Russell, 1990; Giffard et al., 1993) that contains several different homologous repeats
(Ferretti et al., 1987; Russell, 1990; Giffard et al., 1991; Monchois et al., 1998). The
organization and number of repeats vary with the different glucansucrases. Although GBD is
not directly involved in either sucrose cleavage, glucan synthesis or oligosaccharide
synthesis, its presence modulates the initial rate of the reaction (Ferretti et al., 1987; Abo et
al., 1991; Kato et al., 1992; Lis et al., 1995). Truncation of the C-terminal end suppresses
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glucan binding abilities of the GTF of S. sobrinus. The repeat region is not directly involved
in the solubility of the glucan produced (Nakano and Kuramitsu, 1992) but oligosaccharide
size distribution is modified when the C-terminal domain is partially deleted (Monchois et
al., 1998; Remaud-Simeon et al., 2000)
4.1.2 Mechanism of Action
Enzymological studies have led to different models for the mechanism of the action. The use
of secondary structure prediction has led to a clearer knowledge of structure-function
relationships of glucansucrases. However, mainly due to the large size of these enzymes,
data on the three-dimensional structure of glucansucrases (given by crystallography and
modeling) necessary to clearly identify those features that determine function is missing
(Monchois et al., 1999b).
4.1.2.1 Glucan (Dextran) Synthesis
Dextransucrases catalyze the synthesis of high molecular weight glucans (dextrans)
according to the reaction:
dextransucrase
n G-F

Gn +

(sucrose)

dextran

nF
fructose

Dextran is a D-glucose polymer composed mainly of α-1,6 linked backbones in a linear
chain and α-1, 2, α-1,3, and/or α-1,4 branch linkages (Jeanes et al., 1954). The chemical
structure of the dextran is specific to the glucansucrase of the producing strain (Table 3).
Usually a high molecular weight dextran (106-107 Da) is produced. This is the case, for
example, of the enzyme from L. mesenteroides NRRL-512F, which is used to produce
dextran

polymers

of

industrial

interest
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including

chromatography

supports,

Table 3. Linkages in different dextrans as obtained by methylation analysis
Linkages %
Dextran a

Solubility

L. m. B-512F

α-1→3 Br b

α-1→6

α-1→3

Soluble

95

5

L. m. B-742

Soluble

50

L. m. B-742

Less soluble

87

L. m. B-1299

Soluble

65

L. m. B-1299

Less soluble

66

L. m. B-1355

Soluble

54

L. m. B-1355

Less soluble

95

5

S. m. 6715

Soluble

64

36

S. m. 6715

Insoluble

4

α-1→2 Br b

α-1→4 Br b

50
13
35
1
35

94

a

27

11

2

L. m., Leuconostoc mesenteroides; S. m., Streptococcus mutans.b Br, Branch linkage.
Adapted from Robyt 1986
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photographic emulsions, iron carrier, and blood plasma substitutes (Robyt, 1986).
Mechanistic studies of production of dextran from B-512F and mutan from S. mutans 6715
have indicated that formation of a covalent bond between the enzyme and sucrose initiates
synthesis (Figure 2A). In glucose or fructose medium, in the absence of sucrose,
Leuconostoc mesenteroides produces extracellular dextransucrases, although, at levels much
lower than in the presence of sucrose (Dols et al., 1998). Sucrose is the only known practical
inducer. Dextransucrase production is restricted to the active growth phase (Robyt and
Walseth, 1978). The destination of glucosyl residues from sucrose will be a pathway;
dextran if it goes to a polymer being synthesized, oligosaccharides if it is added to an
acceptor. Dextransucrase is believed to work by a single chain mechanism (Robyt and
Taniguchi, 1976), where the enzyme normally remains attached to the growing dextran
chain at the reducing end of the polymer. The enzyme hydrolyzes sucrose, transferring the
D-glycopyranosyl residue to a glucose chain. The termination step of the reaction is not
completely understood, but under normal conditions dextransucrase seems to be released
slowly from the polymer (Ditson and Mayer, 1984).
Glucan synthesis initiation can occur in the absence of an exogenous primer, but
addition of exogenous glucan makes the enzyme more active (Robyt and Corrigan, 1977).
Elongation of glucan, especially the mechanism of autopolymerization and direction of
chain growth, is still not fully understood. It is most likely that the elongation of glucan
occurs at the reducing end of the glucan chains (Robyt et al., 1974; Robyt and Martin, 1983;
Ditson and Mayer, 1984). It has been proposed that glucan synthesis is a result two
nucleophilic sites in the active site of the enzyme that attack sucrose and displace fructose
producing two β-glucosyl intermediates (Robyt 1986). The two nucleophilic sites first
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n times

A. Dextran synthesis

B. Acceptor reaction

C. Formation of branch linkages in dextran
Figure 2. Various mechanisms for the synthesis α-1,6 glucan by L. mesenteroides B- 512F
(ATCC 10830). ο<, sucrose; X1 and X2, nucleophiles of active site in enzymes; nn in B,
acceptor (isomaltose or maltose). Adapted from Robyt 1986
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attack two sucrose molecules and result in two glucosyl residues covalently linked to the
enzyme. Secondly, the C6-OH group of one of the glucosyl residues attacks C1-OH of the
other to form an α-1,6 linkage and one glucosyl residue is transferred to the other. The freed
nucleophile attacks another sucrose molecule, forming a new enzyme glucosyl intermediate.
The C6-OH of this new glucosyl intermediate attacks the C1 of the isomaltosyl unit (the
growing dextran chain), which is in effect transferred to the glucosyl residue. The glucosyl
and dextranosyl units are alternately transferred between the two nucleophiles as the dextran
chain is elongated at the reducing end. As these steps are repeated, the glucan elongation
continues. The elongation is terminated and the chain released by acceptor reactions, one of
which may be with an exogenous dextran chain to give a branch linkage (Robyt, 1986).
Monchois et al. (1999b) pointed out that this proposition is not a perfect explanation of
glucan synthesis because, up to now, only one site (an aspartic acid) capable of making a
covalent bond with the glucose moiety coming from the breakdown of sucrose has been
identified (Mooser and Iwaoka, 1989) and it is difficult to understand how the C6-OH group
is able to attack the C1-OH of the other glucosyl residues by this mechanism.
4.1.2.2 Oligosaccharide Synthesis (Acceptor Reaction)
In 1952, Koepsell et al. (1952) described the synthesis of oligosaccharides at the expense of
dextran synthesis. In the presence of sucrose, they observed that introduction into the
reaction medium of molecules, like maltose, isomaltose, and O-α-methylglucoside, shifted
the pathway of glucan synthesis towards the production of oligosaccharides (Figure 2B).
The enzyme was shown to transfer the D-glucosyl group of sucrose to mono- or
disaccharides such as glucose, maltose or isomaltose, which were called acceptors (Koepsell
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et al., 1952). Since then, the so-called “acceptor” reaction catalyzed by the
glucosyltransferase from L. mesenteroides NRRL B-512F has been extensively described.
Acceptors can substitute for the glucopyranosyl residue, terminating chain growth.
These compounds do not act as primers, but rather they terminate polymerization (Robyt
and Walseth, 1979). The order of preference for chain terminating acceptors of the dextran
reaction is species specific. Many sugars acting as acceptors are classified both according to
their capacity to divert the glucosyl residues from dextran to form oligosaccharides and by
their effect on the rate of reaction. Among acceptors, maltose and isomaltose have been
demonstrated to be the most effective acceptors for dextransucrase (Robyt and Walseth,
1978; Robyt and Ecklund, 1983). Because of its high acceptor efficiency, maltose has been
widely used in the cell free synthesis of oligosaccharides by dextransucrase (Smiley et al.,
1982).
The acceptor efficiency of a large variety of sugars (monosaccharides, disaccharides,
dextran) and the structure of the synthesized products has been determined. Maltose and
isomaltose were found to be the most efficient acceptors among the mono- and disaccharides
(Robyt, 1986). In both cases, the enzyme transfers the glucosyl group to the non-reducing
end of the disaccharide by synthesis of an α-1,6 glucosidic bond. The acceptor reaction
product may in turn be glucosylated and a series of linear oligosaccharides is produced.
(Remaud et al., 1992). The mechanism of acceptor reaction proposed by Robyt and Walseth
(1978) was that only one covalent glucosyl-enzyme complex is necessary and acceptor
molecules will be incorporated at the reducing end of the glucan or the oligosaccharide
produced. Oligosaccharide elongation might occur at the reducing end. Oligosaccharides
may be synthesized by a nucleophillic attack of the hydroxyl group located at the non-
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reducing end of the acceptor to the C1 of one of the two glucosyl residues involved in the
two covalent glucosyl-enzyme complexes.
Various experiments have shown that the acceptor-binding site is really unique and
separated from the two active sites, but, up to now, there is no direct evidence that a separate
acceptor binding site exists (Monchois et al., 1999a). Moreover, one of the two sucrosebinding sites may also be an acceptor-binding site. In DSR-S from L. mesenteroides NRRLB512F, a change from Asp-551 as the site of glucosyl enzyme complex formation to
asparagine, resulted in a total loss of both glucan and oligosaccharide synthesis activities. In
the presence of maltose, the formation of the glucosyl-enzyme complex becomes the
limiting step instead of the polymer transfer, as is the case in glucan synthesis. This might be
due to a change of acceptor binding in dextransucrase. The reason why weak acceptors, such
as fructose, inhibit the reaction remains unclear. A possible explanation is that these
acceptors inhibit sucrose breakdown or the presence of fructose may create a steric
hindrance inhibiting the growth of the glucan chain (Monchois et al., 1999b).
4.1.2.3 Branch Formation
Glucan can also be regarded as an acceptor. An increase in the molecular weight of
exogenous glucan by acceptor reaction was noticed (Cote and Robyt, 1983). The transfer of
glucose and glucan to a glucan chain acceptor has been shown with a dextransucrase
produced by L. mesenteroides NRRL B-512F. The phenomenon of insolubilization of
exogenous glucan by formation of α-1,3 linkages has also been shown with different
glucansucrases. A possible explanation for formation of α-1,3 linkages is they may be the
result of acceptor reactions (Ebert and Brosche, 1967) because an α-1,3 linkage is created
between the anomeric carbon involved in one covalent glucosyl enzyme complex and the
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OH-C3 of a glucosyl residue of the exogenous glucan (Robyt and Taniguchi, 1976; Figure
2C). The exogenous glucan may bind in another site and one of the hydroxyl groups may
exert a nucleophillic attack on the C1 involved in the glucosyl or glucanosyl enzyme
complex. However, this explanation is insufficient to explain the synthesis of highly
branched glucans (Kim and Robyt, 1996). Cote and Robyt (1984) explained α-1,3 linkages
of a highly branched glucan might be synthesized by transfer of a glucosyl residue from a
glucosyl enzyme site different from the two active sites to the glucan. (Monchois et al.,
1999b)
5. Leuconostoc mesenteroides ATCC 13146 (NRRL B-742) and Its Dextransucrase
5.1 Enzyme
Leuconostoc mesenteroides ATCC 13146 was isolated first by Hucker and Pederson (1930)
from spoiled canned-tomatoes. The dextran produced by ATCC 13146 is highly branched,
containing as much as 50% α-1,3 linkages and no α-1,4 linkages. The majority of the branch
linkages connect only a single glucose to the main chain (Seymour et al., 1979a).
Leuconostoc mesenteroides ATCC 13146 actually produces two exocellular α-D-glucans, a
fraction L, which is precipitated at an ethanol concentration of 39%, and a fraction S, which
is precipitated at a concentration of 45% ethanol (Robyt, 1986). Fraction L consists of an α1,6 backbone with α-1,4 branch-points, and fraction S consists of an α-1,6 backbone with α1,3 branch-points. The L fraction from Leuconostoc mesenteroides ATCC 13146 contains
87 % α-1,6 linkages and 13% α-1,4 linkages. The percentage of α-1,3 branch-points in the
fraction S glucan is variable, dependant on the conditions under which it is synthesized from
sucrose. The S fraction is a polymer similar to alternan. However, the α-1,3 linkages of the
S fraction of L. mesenteroides ATCC 13146 are all branched linkages. This dextran
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demonstrates extreme resistance to endodextranase. This property seems related to its
structure that has the highest possible degree of branching and exhibits a comb-like structure
with main chains of consecutive α-1,6 linked glucose residues to which single α-1,3 linked
glucosyl residues are attached. (Seymour et al., 1979b). Any change in reaction conditions
that affects the rate of acceptor reaction relative to chain elongation also affects the degree
of branching in ATCC 13146 fraction S dextran.
This glucansucrase is also capable of modifying other dextrans, such as B-512F
(ATCC 10830) and B-742 (ATCC 13146) fraction L, by transferring D-glucosyl groups to
OH-C3 of D-glucosyl residues in these dextrans (Cote and Robyt, 1983). Denaturating SDSPAGE showed that the ATCC 13146 strain grown on glucose or sucrose has one activity
band at 184kD. The pH optimum range was 5.2 – 5.8 with the highest activity at pH 5.5. The
optimum temperature range was 30 - 37°C with the highest stability at 35°C (Kim and
Robyt, 1995).
5.2 Oligosaccharides by Acceptor Reaction
Glucooligosaccharides are produced by glucosyltransferases (dextransucrase), the
same enzyme that makes dextran (Figure 3). Sugar transport and phosphorylation are key
elements controlling oligosaccharide production by microbial cells, but there is a shortage of
information on these processes in L. mesenteroides ATCC 13146. In general, Leuconostoc
mesenteroides synthesizes several key enzymes; i.e. sucrose phosphorylase and
dextransucrase to utilize sucrose (Kagan et al., 1942; Kobayashi et al., 1986). Regulation of
dextransucrase is controlled by the carbon source (Dols et al., 1998). Sucrose is transported
into the cell via a permease(s) (Dols et al., 1998). Then sucrose phosphorylase, a
constitutive enzyme and thought to be located intracellularly, catalyses the hydrolysis of
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Fructose
Maltosea

Glucooligosaccharides

Sucrose
Glucose
Dextransucrase

Sucrose

Glucose-p
Phosphoketolase pathway
Fructose

Xylulose-5-P

Lactate, acetate,
ethanol, CO2

Mannitol

Figure 3. Schematic representation of carbon flow by Leuconostoc mesenteroides ATCC
13146 during metabolism. The large circle and triangle represent a cell and active site of
polymerization, respectively. a. Maltose is an example of an acceptor.

31

sucrose, adding inorganic phosphate to the glucose moiety of the sucrose molecule
producing fructose and glucose-1-phosphate. (Vandamme et al., 1987; Weimberg et al.,
1954).

Because

Leuconostoc

does

not

have

a

phosphoenolpyruvate:

hexosephosphotransferase system, these bacteria phosphorylate glucose and fructose via
ATP-dependant enzymes (Romano et al., 1979; Sapic and Anderson, 1967; Romano, 1987).
Glucose-1-phosphate is used to support cell growth or dextransucrase production. Dextran
(or oligosaccharides if an acceptor is available) and fructose are produced by the
dextransucrase (Miller et al., 1986). Dextransucrase secretion in L. mesenteroides is
dependent on a presence of proton gradient across the cytoplasmic membrane that is directed
into the cell (Otts and Day, 1988).
Under anaerobic conditions, L. mesenteroides, a heterofermentative lactic acid
bacteria, produces ethanol, lactic acid, and CO2 in equal molar quantities, as byproducts
from glucose, via the phosphoketolase pathway (DeMoss et al., 1951). Increasing acetate
production at the expense of ethanol production produces an additional ATP from the
catabolism of glucose under aerobic conditions but presents a redox problem for the cell, as
it needs to generate NAD+ for catabolic functions (Ito et al., 1983). In many strains of L.
mesenteroides, the regeneration of NAD+ is through an NADH oxidase that utilizes oxygen
as an electron acceptor to oxidize NADH (Ito et al., 1983; Lucey and Condon, 1986). Better
growth is achieved by strains of L. mesenteroides when they produce acetate at the expense
of ethanol. (Johnson and McCleskey, 1957; Lucey and Condon, 1986). However, not all
strains produce NADH oxidase or generate acetate from acetyl-phosphate. These cannot
make an additional ATP during glucose fermentation.
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Yoo (1997) optimized reaction conditions including medium pH, temperature, and
ratio of sucrose to maltose for oligosaccharide production by acceptor reaction. The process
for oligosaccharide production in this study was performed using a modification of his
procedures.
In the presence of an efficient acceptor sugar, such as maltose, the reaction of a
dextransucrase is shifted towards oligosaccharide synthesis. The molecular weight and
polydiversity of this enzyme product are dependent upon the sucrose to acceptor ratio and
on the characteristics of the intermediate oligosaccharides in the reaction. The ratio of
sucrose to maltose affects the composition and yield of the oligosaccharides produced by the
acceptor reaction. Paul et al. (1986) reported, when the maltose to sucrose ratio was 2, a
partially purified dextransucrase from L. mesenteroides NRRL B-512F produced 85% of the
theoretical yield of polysaccharide as oligosaccharides, with an average DP of 4. Cote and
Robyt (1983) investigated the acceptor reaction of L. mesenteroides ATCC 13146 and found
that branch formation in this strain, when maltose was the acceptor, was dependant upon
reaction conditions. In Yoo’s (1997) study, L. mesenteroides ATCC 13146 in the presence
of maltose produced 90% of the theoretical yield of polymer as oligosaccharides, under
optimum conditions for sucrose fermentation. The fermentation was essentially complete in
24 hours, with oligosaccharide production being linked to growth. The production rate was
about 0.9 g/L hr. The maltose to sucrose ratio was able not only to alter the yield of
oligosaccharide but also to change the relative proportion of different size oligosaccharides
produced by the fermentation. The highest yields of oligosaccharides were obtained when
the ratio of sucrose to maltose in the fermentation was two. This is the same ratio reported
for optimum oligosaccharide production in vitro by the dextransucrase of L. mesenteroides
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B-512F (Paul et al., 1986). Several Leuconostoc strains were tested to check for
oligosaccharide size profiles produced in response to maltose, because individual
Leuconostoc species synthesize different dextransucrases in response to various acceptors.
The oligosaccharides produced by L. mesenteroides ATCC 13146 were mostly DP 3-5
glucooligosaccharides by chemical analysis. Oligosaccharides prepared by drying alcohol
precipitated cell free culture broths had greater amounts of higher branched
isomaltooligosaccharides up to DP 7, than commercial preparations and had no glucose and
less maltose (Yoo, 1997).
5.3 Mannitol as Byproduct
D-mannitol is a sugar-alcohol derived from mannose or fructose by dehydrogenation.
In sucrose fermentations, mannitol is produced as an end product, as fructose can be used as
an electron acceptor, but the levels of mannitol produced vary with the strain (Ferain et al.,
1996; Loesche and Kornman, 1976; Grobben et al., 2001). The production of mannitol from
fructose by lactic acid bacteria was first observed by early studies in the 1900’s (Perterson
and Fred 1920). The intracellular and NADH-dependent microbial enzyme, D-mannitol
dehydrogenase (E.C. 1.1.1.67), converts fructose to mannitol (Vandamme et al., 1987).
Several species including Lactobacillus brevis, Leuconostoc mesenteroides, Agaricus
campestris, and Aspergillus candidus were reported as the enzyme producing strains (Yoo,
1997). The mannitol produced is excreted by the cell (Vandamme et al., 1987). The
conversion of fructose to mannitol allows the cell to maintain its redox balance, thus, not all
acetyl-phosphate is reduced to ethanol. Extra ATP is then available for the cell under both
aerobic and anaerobic conditions, when grown on sucrose (Otts, 1987).
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Mannitol is used not only in foods but also has wide application in the non-food
sector. Mannitol is commonly used in pharmaceutical formulations of chewable tablets and
granulated powders (Soetaert et al., 1995; Debord et al., 1987). A complex of boric acid
with mannitol is used in the production of dry electrolytic capacitors. It is an extensively
used polyol for the production of resins and in many types of surfactants. Mannitol is used in
medicine as a powerful osmotic diuretic and in many types of surgery for the prevention of
kidney failure and to reduce eye and brain edema. One of its derivates, mannitol hexanitrate,
is a well-known vasodilator, used in the treatment of hypertension. Nowadays mannitol is
produced exclusively by catalytic hydrogenation of fructose. Worldwide production is
estimated at about 30,000 tons per year.
The commercial production is performed by high-pressure hydrogenation of
glucose/fructose mixtures (invert sugar or isoglucose) at high temperature with Raney-nickel
as the catalyst (Wisniak and Simon, 1979). In the hydrogenation process the selectivity of
the nickel catalyst is such that about half of the fructose is converted to mannitol and half of
it to sorbitol. The glucose is hydrogenated exclusively to sorbitol. As a consequence,
commercial production is always accompanied by the production of sorbitol, thus resulting
in a less efficient process. The composition of the hydrogenated mixture is typically about
25-30% mannitol and 70-75% sorbitol. Mannitol is then recovered by crystallization, as it is
far less soluble than sorbitol. Consequently the price of mannitol is about three times as
high as that of sorbitol. Mannitol can also be produced by fermentation (Figure 4). Various
studies using fungi and yeasts have been undertaken but none of these processes was
economically successful (Soetaert et al., 1995). The enzymatic conversion of fructose to
mannitol is also possible, but suffers from serious drawbacks such as incomplete conversion
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Figure 4. Schematic representation of carbon and energy flows through the central metabolic
pathways of L. mesenteroides. G6P, glucose 6-phosphate; F6P, fructose 6-phosphate; 6PG,
6-phosphogluconate; 2K6PG, 2-keto-3-deoxy-6-phosphoglucanate; G3P, glyceraldehydes-3phosphate; acetylphosphate; 1,3diPG, 1,3-diphosphoglycerate; acetylCoA, acetyl coenzyme
A; 3PG, 3-phosphoglycerate; PEP, phosphoenolpyruvate (Adapted from Salou et al. 1994).
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and especially the high cost of the cofactor NAD(P)H (Kulbe et al., 1988). Leuconostoc
mesenteroides is capable of using fructose as an alternative electron acceptor, reducing it to
mannitol (Soetaert et al., 1995). Mannitol was found as one of major end products in our
Leuconostoc fermentation. It would be necessary to separate the mannitol from the
oligosaccharides if they are to be used as bifidobacteria growth factors, because mannitol
can be a carbon source. Its presence would hinder studies on the effect of oligosaccharides
on intestinal microflora. Bart et al. (1996) conducted separation of mannitol from a mixture
of fructose and sorbitol using a continuous chromatographic separation method. However,
there have been no attempts to separate mannitol from oligosaccharides
6. Starch Digestion and Intestinal Microflora
Starch is one of the most available fermentable sources of energy for organisms and makes
up 60 – 70% of dietary carbohydrate of humans (Gray, 1970). Starch is a glucose polymer,
composed of amylose (α-1,4 linked glucosyl linear chains of an average molecular weight
(M.W.) of 100 kDa (~600 glucose units) and amylopectin (an α-1,4 and α-1,6 branched
linked glucose polymer, -linked (M.W. 1000 kDa, ~6000 glucose units) (Gray, 1992).
In humans, a secreted pancreatic α- amylase cleaves starch to a di- (maltose), tri(maltotriose), and branched α-dextrins in the duodenal cavity. Because there is no integral
transport process in the intestinal enterocyte that can accommodate anything larger than free
glucose, these oligosaccharides are further processed to glucose in the intestinal surface
membrane by α-glucosyl saccharidases. These enzymes are a large glycoprotein component
of the intestinal surface brush border membrane. They contain enzymes such as sucrase, αdextrinase, and glucoamylase (Gray, 1991). Glucose then may be cotransported into the
enterocyte, along with Na+, either by a 75kDa specific integral brush border glucose carrier
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or by a transporter expressed in the small intestine (Hediger et al., 1987). Almost all of the
free glucose is transported into the enterocyte (Smithson et al., 1981). Digestion ranges for
dietary carbohydrates varies by food type, for example, 81% for baked beans, 90% for
whole oats, and 99% for rice (Levitt et al., 1987). The digestion differences are attributed to
the presence of α-amylase inhibitors in food, or different rates of wetting of the starch
components from the depths of the grain or legume, or to the presence of non-digestible
carbohydrates (dietary fibers). However, a proportion of the unprocessed amylose and
amylopectin passes all the way through the intestine to the colon where it can be
metabolized by intestinal microflora (Gary, 1991).
The microflora is similar to that of the feces, where anaerobic bacteria comprise
more than 90% of all the organisms present. In adults, Bacteroides and bifidobacteria are
dominant groups followed by Eubacteria, Peptostreptococci. The most numerous bacterial
species include: Bifidobacterium adolescentis and Bifidobacteium longum, Bacteroides
fragilis, Peptostreptococcus productus, Eubacterium aerofaciens and Ruminococcus bromii.
Many other organisms occur in small groups such as Ruminococci and Clostridia,
Staphylococci, aerobic sporeformers, yeast and Proteus (Rasic and Kurmann, 1983). These
bacteria all compete for the unprocessed starch molecules that reach the large intestine. Most
of Bacteroides and Enterobacteriaceae rapidly utilize starches as carbon sources whereas
utilization of starch by Bifidobacteria varies depending on the species (Krieg and Holt,
1984; Sneath et al., 1984; Crittenden et al. 2001).
7. Potential Applications
Antibiotic-associated gastrointestinal disturbances are a well-recognized problem.
Antibiotic or drug therapy can significantly affect the bifidobacteria balance in the intestine
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(Alestig et al., 1983; O’Sullivan and Kullen, 1998). Restoring this balance rapidly is
considered necessary to reduce the possibility of intestinal pathogens increasing in numbers
and becoming established. Some studies have reported that ingesting bifidobacteria can help
the restoration process (Korshunov et al., 1985). Black et al. (1991) observed that B.
longum, delivered with Lactobacillus acidophilus, decreased the incidence of ampicillinassociated diarrhea, the time required for recolonization of the intestine, and the
concentration of Bacteroides in the feces. Further, Colombel et al. (1987) have shown an
alleviation of erythromycin associated diarrhea, by administration of yogurt containing B.
longum. In addition to their therapeutic value in situations of antibiotic treatment,
bifidobacteria can be effective at alleviating diarrhea caused by rotavirus-induced diarrhea in
infants and appears to offer a promising treatment for this disorder (Duffy et al., 1994;
Saavedra et al., 1994; Yasui et al., 1995; O’Sullivan and Kullen, 1998). Apart from
oligosaccharide usage in foods, oligosaccharides have application in animal feeds. With the
rise in antibiotic resistance and the subsequent removal of antibiotics from animal feed there
is a need for alternatives that can reduce the incidence of Salmonella enterica and
pathogenic Escherichia coli in animals. However, appropriate models are needed (Naughton
et al., 2001). There are an increasing number of reports of antibiotic-resistant infections in
humans that can be transferred from the food supply attributed to the use of drugs on
livestock and poultry.
During recent years, poultry production and consumption have continuously
increased. The production of broilers increased from 9,482,000 tons in 1992 to 14,017,000
tons in 1996 in the United States (Olentine, 1997). Poultry is a carrier of numerous bacteria,
including Salmonella and Campylobacter, which are causes of food-bone outbreaks.
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Practical experience has demonstrated that it is difficult to reduce the percentage incidence
of Salmonella on chickens below that already on the outside surface of chickens when they
arrive at the processing plant. Significant reduction in Salmonella on processed broiler
carcasses will require the delivery of Salmonella –reduced chickens to the processing plant.
One of possible ways to control Salmonella levels can be the addition of selected
carbohydrates to the diet of chickens. Mannose, or lactose in the diet of chickens has been
reported to reduce Salmonella colonization (Oyofo et al., 1989). Fructooligosaccharides
(FOS) have been shown to influence intestinal bacterial populations by enhancing the
growth of lactic acid bacteria such as Lactobacillus species and Bifidobacteria (Bailey et al.,
1991). Fukata et al. (1999) reported the inhibitory effects of fructooligosaccharides on
Salmonella colonization of chicks. The mean number of Salmonella enteritidis in the chicks
of the fructooligosaccharide group was significantly (P<0.05) decreased compared with the
control group.
The aims of the present research are 1) to develop an industrial production method
for oligosaccharides and mannitol using a L. mesenteroides ATCC 13146 fermentation with
sucrose and maltose and 2) to demonstrate the effectiveness of these oligosaccharides as
prebiotics for poultry.
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MATERIALS AND METHODS
1. Organism, Culture Medium, and Inoculum Preparation
All strains of bacteria used in this study were obtained from the American Type Culture
Collection (ATCC, Manassas, VA). They were maintained on agar slants, at 4°C and
transferred monthly. Anaerobes were subcultured weekly. Salmonella typhimurium ATCC
14028 and Escherichia coli B ATCC 23226 were maintained on tryptic soy agar (Difco,
Detroit, MI). Bifidobacterium bifidum ATCC 35914, Bifidobacterium longum ATCC 15708,
Lactobacillus johnsonii ATCC 33200 and Leuconostoc mesenteroides ATCC 13146 were
maintained anaerobically on Lactobaccilli MRS slants (Difco, Detroit, MI) containing
0.05 % (w/v) cystein. Chicken ceca were kindly supplied by Dr. Siragusa, G. (USDA ARS,
Russell Res. Ctr., Athens, GA). Screening and isolation for chicken ceca bacteria were
conducted following the method described by Hartemink and Rombouts (1999). Basically,
ceca (from 6 weeks to 8 weeks broilers) in a plastic bag, were homogenized by kneading the
bag and a subsample of ~ 10 g was transferred to a preweighed glass container containing 90
ml anaerobic buffered peptone water (Oxoid) with 0.5 g/L L-cystein-HCl. The container was
then closed and weighed to determine the actual sample size. Mixed samples were diluted
further with reduced physiological salt solution (rps, peptone 1 g/L, L-cystein-HCl 0.5g/L
and NaCl 8g/L) or test media (MRSB). Finally, the samples were plated on the media and
incubated at 37°C for 48 h. Unless otherwise stated, mixing, diluting, plating and incubation
were carried out anaerobically. Six colonies out of the hundreds were selected randomly and
designated as chicken ceca bacterium #1 to #6.
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2. Preparation of Oligosaccharides
Batch fermentations were conducted in a 2-L BioFlo II fermentor (New Brunswick
Scientific Co.) with a working volume of 1.0 L. The media had the following composition:
sucrose (100g/L); maltose (50g/L); yeast extract (5g/L); MgSO4·7H2O (0.2g/L);
FeSO4·7H2O (0.01g/L); NaCl (0.01g/L); MnSO4·7H2O (0.01g/L); CaCl2 (0.05g/L);
KH2PO4 (3g/L) with pH 7.2. Fermentors were inoculated from late log phase flask cultures
at 1.0% of working volume. Fermentations were conducted at pH 6.5, 28ºC, and 200 rpm.
After harvesting, cells were removed by centrifugation at 10,400 x g for 20 min (Dupont
Sorvall RC5C, Newtown, CT). Activated charcoal (5g/L, Sigma Chem. Co., St. Louis, MO)
and Celite 545 (1g/L, Fisher Scientific, Fair Lawn, NJ) were added to cell-free culture broth
and mixed at 50ºC for 20 min. The broths were then filtered through No. 6 filter paper
(Whatman International Ltd., Maidstone, England) to remove the carbon. The filtered broths
were desalted using ion-exchange columns filled with an anion-exchange resin in the
hydroxide form and a cation-exchange resin in the hydrogen form (Rohm and Haas,
Philadelphia, PA). The eluents were concentrated by vacuum evaporation (Brinkmann
Instrument Inc., Westbury, NY) to 65 % solids. Mannitol crystallized upon cooling the
concentrates and was removed by decantation. Oligosaccharides were separated from the
mannitol free concentrates using a cation exchange column (in calcium form); the
oligosaccharide fractions were concentrated by vacuum evaporation.
3. Analytical Methods
Bacterial growth was measured by turbidimetry at 650 nm, calibrated against cell dry weight.
Cells from a known volume were harvested by centrifugation at 10,400 × g, for 2 min
(Dupont Sovall 24S, Newtown, CT), washed with deionized water, resuspended in a
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minimum volume of water, and dried (initially overnight at 95 °C and then at 105 °C) to
constant weight. An absorbance of 1.0 at 660nm was equivalent to 0.51g of dry matter⋅liter-1.
• TLC – Separation and qualitative identification of oligosaccharides was conducted using
TLC. Whatman K6F silica gel plates of sizes (10 × 20 cm) were obtained from Fisher
Scientific (Chicago, IL). A homologous series of isomaltodextrins (DP 1-10) was kindly
donated by Dr. Doman Kim (Chonnam National Univ., Kwangju, Korea). Maltopentaose,
maltohexaose, maltoheptaose, pannose, and isomaltotriose (Sigma Chem. Co., St. Louis,
MO) were used as standards. Aliquots (1-2 µL) of the solutions to be analyzed were applied
20 mm from the bottom of the TLC plates with 10 µL microsyringe pipets. The plates were
developed at ambient temperature, using a mixture of solvents (acetontrile, ethylacetate,
propanol, and water in volume (mL) proportions of 85: 20: 50: 70). After development was
complete, the plates were dried, the carbohydrates visualized using a spray of an ethanol
solution containing 0.3 % (w/v) α-naphthol and 5 % (v/v) H2SO4. After air-drying, spots
were developed by heating in an oven for 10 to 20 mins at 100°C. Glucooligosaccharides
were identified by comparing their chromatographic behavior with those of the standards.
• Cation column tests – Different types of cation resins (Na, K, Ca form) were tested for
separation of oligosaccharides from the end fermentation products. Resins (Duolite CR1320, Rohm and Haas, Philadelphia, PA) in glass jacketed columns (10 mm (Inner diameter)
× 100 mm (Length), working volume 70 ml ) were regenerated using 5% solutions of NaCl,
KCl, or CaCl. Temperature of the water eluent and the circulating water for glass jacket
were 92 and 80 °C, respectively, and no pressure on the column was applied. Injection
volume was 1 ml of solution (15 Brix° GOS). The detector was a differential refractometer
(Waters).
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• High-performance ion chromatography using a CarboPac MA1 column (Dionex,
Sunnyvale, CA) and a pulsed amperometric detector (PAD, Dionex) was used to analyze for
quantitative analysis of glucose, fructose, sucrose, mannitol and maltose concentrations in
solution. The samples were eluted at 0.4 ml⋅min-1 with a 0.48 M NaOH solution.
Oligosaccharide concentrations were calculated from peak areas of high-performance liquid
chromatography on an Aminex-HPX-87K Bio-Rad column (Bio-Rad Lab. Hercules, CA)
run at 85 °C with K2HPO4 as eluent, at a constant flow rate of 0.5ml⋅min-1, using glucose as
a standard.
•

13

C NMR – The oligosaccharides (DP 1 to DP 8) were analyzed using a DPX 250 (63

MHz 13C) system with help of Mr. Yang, J. (Dept. of Chemistry, LSU). The chemical shifts
were expressed in ppm relative to the methyl signal of acetone in deuterium oxide solvent
which was used as an internal standard at δ = 29.92 ppm. The various signals were assigned
as described by Seymour et al. (1976a) and Remaud et al. (1992).
• Kinetic assay for α-glucosidase – α-glucosidase (maltase; EC 3.2.1.20), β-NAD, glucose
dehydrogenase (EC 1.1.147) and other reagent chemicals were obtained from the Sigma
Chemical Co. (St. Louis, MO). The kinetic assays were based on the following reaction;
G-Gn
(maltose)

α-glucosidase

glucose dehydrogenase
Gn
(glucose)

G-COOH
(glucuronic acid)
β-NAD

β-NADH2

The kinetic assays were all performed in 96-well plates and read at wavelength 320
nm in a SPECTRAmax Plus microtiter plate reader (Molecular Devices Corp., Sunnyvale,
CA) at 37°C. Their software package Softmax was used for data analysis. α-Glucosidase
(maltase; EC 3.2.1.20), β-NAD, and glucose dehydrogenase (EC 1.1.147) solutions were
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prepared with 0.1M K2HPO4 (pH 7) buffer. Each well contained 25µl of 0.13 IU/ml glucose
dehydrogenase, 25µl of 1.65 IU/ml of α-glucosidase, and 20µl of 12 mM of β-NAD in a
total volume of 200µl with different combinations of sugars and 0.1M K2HPO4 (pH 7)
buffer. Absorbance change with time was measured at 320nm.
4. Oligosaccharide Utilization by Selected Microorganisms
The growth of selected bacteria in the presence of oligosaccharides was compared by
measuring absorbances over time at 660 nm. The media used for both the Bifidobacteria sp.
and L. johnsonii was of the same composition as Lactobacillus MRS broth with 0.05 %
(w/v) cystein, except the carbon source was replaced by various oligosaccharide
preparations. The growth media for S. typhimurium and E. coli was tryptic soy broth, with
the carbon source replaced by various oligosaccharide preparations. Carbon sources were
supplied at a final concentration of 0.5 % (w/v). All carbon sources were filter sterilized (0.2
µm). The following carbon sources were compared: glucose (Sigma Chem Co., St. Louis,
MO), commercial fructooligosaccharides (FOS; > 97.5 %, Samyang Genex Co., Seoul,
Korea), and oligosaccharide preparations. Individual culture, anaerobic growth tests were
conducted in sealed glass test tubes. Each tube was inoculated from an overnight culture
with either S. typhimurium or E. coli and a 24 to 48 hr culture of a Bifidobacteria sp. or L.
johnsonii. The experiments with Bifidobacteria sp. and L. johnsonii were conducted under
anaerobic conditions using anaerobic jars (BBL Microbiology Sys., Cockeysville, MD) or
the Oxyrase plate system (Oxyrase, Inc., Mansfield, OH). MRS broth containing 0.05 %
(w/v) cystein with oligosaccharides as a carbon source was used for mixed cultures of S.
typhimurium and L. johnsonii. Total viable counts were conducted on MRS agar and the cell
numbers of S. typhimurium were determined from growth on MacConkey agar plates (Difco,
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Detroit, MI). The cell numbers for L. johnsonii were obtained as the difference between total
viable count and S. typhimurium numbers. TLC was used to determine oligosaccharide
consumption patterns of various strains. The media was MRSB for Bifidobacteria and ceca
bacteria and TSB for S. typhimurium and E. coli containing 0.5% (w/v) of Leuconostoc
glucooligosaccharides instead of glucose as the carbon source. Media pH was adjusted to 6.0
and 0.1% (v/v) inoculum grown overnight in MRSB was used. During the growth, samples
were taken at various times. Samples (2 µl) were applied on TLC plates.
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RESULTS
1. Oligosaccharide Production
• Glucooligosaccharide (GOS) production by acceptor reaction
GOS production was complete by late log phase, about 10 hr post-inoculation, and levels did
not drop thereafter (Figure 5). Sucrose disappeared rapidly during log phase of growth, with
sucrose depletion corresponding to the transition point to stationary phase. Once sucrose was
depleted, the accumulated fructose was metabolized to mannitol with a decrease in growth
rate compared to growth on sucrose. Fructose concentration peaked about the end of log
phase then decreased slowly. Mannitol production occurred through the lag phase to the
stationary phase and was linked to the fructose concentration where the rate of fructose
disappearance was the inverse of the rate of mannitol formation. Oligosaccharide production
was associated with cell growth. The conversion of fructose to mannitol was associated with
the accumulation of fructose. Upon completion of fermentation, the cell mass was 3.2g/L.
The weight % yield of oligosaccharide (product produced × 100 / [(160 × mole of sucrose
consumed) + (342 × mole of maltose consumed)]) was 82 % of theoretical, the number 160
in the equation from 342 (sucrose M.W.) −((180 (fructose M.W.)+ 2 (hydrogen M.W.)) and
the conversion of fructose to mannitol was 71 % of theoretical. Thin layer chromatography
(TLC) clearly showed the course of GOS production (Figure 6). As fermentation proceeded,
mono- and disaccharides disappeared as the higher DP polysaccharides were formed. By 24
hr, all mono- and disaccharides had been converted to higher oligosaccharide polymers.
Four main oligosaccharides were found. The sizes of these oligomers were compared with a
commercial

oligosaccharide

product

of

known

composition.

The

Leuconostoc

oligosaccharides were branched polymers with a size range of DP 1 to 7. The
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Figure 5. Glucooligosaccharide production by L. mesenteroides ATCC 13146 from sucrose
(10 % w/v) and maltose (5% w/v) as a function of time.

48

M5

Glc
M2
IM2
Br3(P3)
IM3
Br4
IM4

M7

IM5
0h

S1

S2

S1

48h 24h

0

6

12 24

Br5
Br6

G,
S
48 td MC2

Time(hr )

Figure 6. TLC of glucooligosaccharide production as a function of time.
S1, maltopentaose standard; S2, maltoheptaose standard; Std, a mixture of glucose and
maltose; C, Commercial isomaltooligosaccharides (Wako Pure Chemical Industry Ltd.,
Osaka, Japan); Glc, glucose; M2, maltose; IM2, isomaltose; Br3(P3), panose; IM3,
isomaltotriose; Br4, branched DP4; IM4, isomaltotetraose; Br5, branched DP5; IM5,
isomaltopentaose; Br6, branched DP6; M5, maltopentaose; M7, maltoheptaose. The solvent
system was a mixture of acetontrile, ethylacetate, propanol, and water (in volume (mL)
proportions of 85: 20: 50: 70). After development was complete, the plates were dried and
the carbohydrates visualized using a spray of an ethanol solution containing 0.3 % (w/v) αnaphthol and 5 % (v/v) H2SO4. Samples were taken at the indicated times during
fermentation.
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oligosaccharides, based on their linkages, showed different Rf values (Figure 7). As
indicated by Robyt and Mukerjea (1994), the migration of branched isomaltodextrins
containing single α-1,3 or α-1,4 linkages, is faster than equivalent dextrins containing only
α-1,6 linkages. The migration of the Leuconostoc oligosaccharides was faster than
equivalent isomaltodextrins (α-1,6 linkages), but slower than equivalent maltodextrins (α1,4 linkages).
• Oligosaccharide separation
The fermentation broth, after cell separation, contained oligosaccharides, mannitol and some
organic acids. Because the oligosaccharides are neutral polymers, and the other components
(acids, color compounds and salts) are charged, cation resins were used for separation of
oligosaccharides. Neither K+ nor H+ cation columns clearly separated the oligosaccharides
from the mannitol and other products whereas Ca2+ cation columns produced two well
separated peaks (Figure 8). The first peak contained all the oligosaccharides and the second
peak did mannitol and organic acids (Figure 9). In the second peak, there were acetic acid
and lactic acid. Based on these results, the process for producing an oligosaccharide product
was developed (Figure 10).
• Mannitol separation
Crystallization at 4 °C separated most of mannitol from oligosaccharides (Figure 11).
Mannitol harvested showed high purity (> 99.0 %, calculated by HPLC peak area). A crude
oligosaccharide mixture can be obtained after crystallization. Using a cation exchange (Ca2+
form) column, pure oligosaccharides mixture (> 98.8 % w/w, Figure 8) was obtained.
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Figure 7. Rf values for oligosaccharides, taken from TLC plates based on linkages.
Isomaltodextrins: α-1,6 linkages, Maltodextrins: α-1,4 linkages
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K + form

Na + form

Ca2+ form
Peak 1
Peak 2

Figure 8. Profiles of mannitol/oligosaccharide separation on different cation resins.
Resins (Duolite CR-1320, Rohm and Haas, Philadelphia, PA) in glass jacketed columns (10
mm (Inner diameter) × 100 mm (Length), working volume 70 ml ) were regenerated using
5% solutions of NaCl, KCl, or CaCl. Temperature of the water eluent and the circulating
water for glass jacket were 92 and 80 °C, respectively, and no pressure on the column was
applied. The detector was a differential refractometer (Waters).
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Peak 2

Peak 1

mannitol

lactate

oligosaccharides

acetate

Figure 9. HPLC chromatogram of the peaks fractionated by Ca2+ cation resin columns.
Fractions were collected from the outlet of glass jacket column as a time function. Each of
the fractions was analyzed on an Aminex-HPX-87K Bio-Rad analytical column (Bio-Rad.
Hercules, CA) run at 85 °C with K2HPO4 as eluent, at a constant flow rate of 0.5ml⋅min-1.
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Fermentation with
Leuconostoc mesenteroides B-742
Cell separation
Deionization and Decolorization
Mannitol crystallization
Product polishing by chromatography
Oligosaccharide product

Figure 10. Flow chart for glucooligosaccharide production.
Cell separation was done by centrifugation at 10,400 × g for 20 min. Deionization and
decolorization was done by ion-exchange. Anion-exchange resin was in hydroxide form and
cation-exchange resin was in hydrogen form. Mannitol crystallized out at 4°C. Ca2+ cation
resin was used for removing residual impurities.
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a

c

b

d

Figure 11. HPLC chromatogram from oligosaccharide processes.
a, broth after deionization; b, broth after mannitol crystallization (86.4% recovered); c,
mannitol product (>99.0% purity); d, oligosaccharide product (>98.8% purity). The arrows
indicate the mannitol peak.
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Pure oligosaccharide solution (14.5 Brix°) was concentrated to 60 Brix° by evaporation. The
concentrated pure oligosaccharides (ca. 60 % w/v) were used for the further testing (Table 4).
• Composition and structure of oligosaccharide products
Thin layer chromatography showed that GOS were branched polymers ranging in size from
DP 2 to 7 (Figure 12). By HPLC peak area, there was 6.9% DP 2, 28.4% panose, 36.7%
branched DP 4, 19.1% branched DP5, 7.4% branched DP6, and 1.2% branched DP7. In the
pure form, there was only a trace amount of monosaccharides (< 0.2 %) present and no
polysaccharides larger than DP 7. Structural analysis of GOS by C13 NMR showed that the
GOS are linked mainly by α-1,4 and α-1,6 linkages (Figure 13). Two closely separated
peaks at 100.44 ppm, α-1,4, that are for specific residues are also encountered in the
spectrum of maltose and both correspond to a glucose molecule linked to a reducing residue
of maltose by an α-1,4 linkage (Remaud et al., 1992). It also implies that the α-1,4 linkage
is located at the reducing end of isomaltosyl residues containing α-1,6 linkages. The peaks
corresponding to the region of 98.0- 99.0 ppm show α-1,6 linked residues. However, The
intensity of the resonances for α-1,3 bonds around 100.0 and 80.6- 81.2 ppm were not
present (Dols et al., 1998; Remaud et al., 1992).
2. Glucooligosaccharides as Microbial Growth Modifiers
• Individual cultures
Growth of selected bacteria on L. mesenteroides ATCC 13146 glucooligosaccharides as a
carbon source was compared with growth on a commercial fructooligosaccharide (FOS)
mixture. Both types of oligosaccharides produced significantly reduced growth of S.
typhimurium and E. coli compared with growth on glucose (Table 5). Based on the TLC
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Table 4. Product yields and process for production of glucooligosaccharides
Process
Components in process
Fermentation

Input

Output

Sucrose (10 % w/v)

100 g/L

Maltose (5 % w/v)

50 g/L

Yeast extract and salts

8.28 g/L

Oligosaccharides

80.1 g/L (82.3 %a)

Mannitol

37.6 g/L (70.1%b)

Acids, ethanol and
cell mass

5.75 g/L

Decolorization
and deionization

Removal of color pigments
and salts

Evaporation

Concentrated to ca. 60 %
(w/v)

Crystallization

at 4°C
Oligosaccharides,
residual mannitol

Mannitol (86.4% recovered,
99.0% purity)

Purified oligosaccharides

98.8% purity

Ca 2+Ion
exchange

a. Weight % yield of oligosaccharide (product produced × 100 / [(160 × mole of sucrose
consumed) + (342 × mole of maltose consumed)])
b. % fructose conversion to mannitol
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Glc
IM3

IM5
IM7
S

P

C

Figure 12. TLC of branched α-glucooligosaccharides of L. mesenteroides (ATCC 13146).
S,
Isomaltodextrins;
P,
Glucooligosaccharide
product;
C,
Commercial
isomaltooligosaccharides (Wako Pure Chemical Industry Ltd., Osaka, Japan); Glc, glucose;
IM3, Isomaltotriose; IM5, Isomaltopentaose; IM7, Isomaltoheptaose. The solvents system was
mixture of acetontrile, ethylacetate, propanol, and water (in volume (mL) proportions of 85:
20: 50: 70). After development was complete, the plates were dried, the carbohydrates
visualized using a spray of an ethanol solution containing 0.3 % (w/v) α-naphthol and 5 %
(v/v) H2SO4.
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Figure 13. 13C NMR of Leuconostoc glucooligosaccharides. These oligosaccharides were
analyzed using a DPX 250 (63 MHz 13C) system. The chemical shifts are expressed in ppm
relative to the methyl signal of acetone in a deuterium oxide solvent, which was used as an
internal standard at δ = 29.92 ppm. The various signals were assigned as described by
Seymour et al. (1976) and Remaud et al. (1992); 85- 105 ppm, the anomeric region (mainly
97- 103 ppm, as there is only an infinitestinal proportion of reducing sugar in any of the
polymers); 70- 75 ppm, C-2,3,4, and 5; 60- 70 ppm, bonded and non-bonded C-6 atoms; 7585 ppm, signals of bonded C-2, C-3, C-4, C-5.
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Table 5. Growth comparison on glucooligosaccharide preparations
GOS, Leuconostoc glucooligosaccharides; FOS, Commercial fructooligosaccharides
(Samyang Genex Co., Seoul, Korea)
Growth rate in exponential growth phase
Growth rate
-1
Organism
([Absorbance unit×100]⋅hr )
(on GOS/
glucose)
glucose
GOS
FOS
9.89

3.64

3.48

36.8

E. coli

9.35

2.68

2.44

28.7

B. bifidum

13.30

9.81

13.10

73.8

L. johnsonii

11.06

10.74

10.70

97.1

B. longum

11.72

11.69

11.70

99.7

S. typhimurium
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analysis, these organisms could not use the glucooligosaccharides, efficiently (Figures 14,
15). There was no significant difference between growth rates on either of the
oligosaccharide preparations. The growth rate suppression of E. coli in the presence of GOS
was marginally greater than that of S. typhimurium (Table 5). The growth of selected
probiotic strains on GOS was also compared. Leuconostoc GOS supported the growth of
Bifidobacterium longum and L. johnsonii and showed no significant difference when
compared to glucose as carbon source. B. longum degraded almost all components of the
GOS within 24 hrs (Figure 16). Utilization of the GOS product by B. bifidum was less rapid
(74.9 % relative to growth rate of FOS) than utilization of a commercial FOS and glucose.
This indicates that the growth of probiotic strains was also dependent on the type of
oligosaccharides.
• Mixed cultures
To test for prebiotic effects of the GOS, mixed cultures of S. typhimurium and L. johnsonii
were grown on the oligosaccharides. When the medium pH was above 5.0, both organisms
grew; however, S. typhimurium grew more slowly than L. johnsonii. As the population of L.
johnsonii increased, the pH dropped (Figure 17). When the pH dropped below 5.0, S.
typhimurium populations decreased, until they were below detection level (< 1).
• Growth of bacteria isolated from chicken ceca on GOS
Utilization of Leuconostoc GOS by six bacterial isolates (all showed Gram positive, catalase
negative and lactic acid formation from glucose) from chicken ceca was compared to
utilization of a commercial fructooligosaccharide (FOS), three of the six bacteria showed
more growth after 24 hr on GOS than on FOS (Table 6). In mixed cultures of chicken ceca
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Figure 14. TLC of anaerobic growth of E.coli B (ATCC 23226) on 0.5%
glucooligosaccharide preparations. .Std, standard; Glc, glucose; IM3, isomaltotriose; IM5,
isomaltopentaose. The solvent system was a mixture of acetontrile, ethylacetate, propanol,
and water (in volume (mL) proportions of 85: 20: 50: 70). After development was complete,
the plates were dried and the carbohydrates visualized using a spray of an ethanol solution
containing 0.3 % (w/v) α-naphthol and 5 % (v/v) H2SO4.
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Figure 15. TLC of anaerobic growth of Salmonella typhimurium (ATCC 14028) on 0.5%
glucooligosaccharide preparations. Std, standard; Glc, glucose; IM3, isomaltotriose; IM5,
isomaltopentaose. The solvent system was a mixture of acetontrile, ethylacetate, propanol,
and water (in volume (mL) proportions of 85: 20: 50: 70). After development was complete,
the plates were dried and the carbohydrates visualized using a spray of an ethanol solution
containing 0.3 % (w/v) α-naphthol and 5 % (v/v) H2SO4.
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Figure 16. TLC of anaerobic growth of Bifidobacterium longum (ATCC 15708) on 0.5%
glucooligosaccharide preparations. Std, standard; Glc, glucose; IM3, isomaltotriose; IM5,
isomaltopentaose. The solvent system was a mixture of acetontrile, ethylacetate, propanol,
and water (in volume (mL) proportions of 85: 20: 50: 70). After development was complete,
the plates were dried and the carbohydrates visualized using a spray of an ethanol solution
containing 0.3 % (w/v) α-naphthol and 5 % (v/v) H2SO4.

64

10

7

9
8
6
S. typhimurium
L. johnsonii

6
5

5

pH

Log CFU / mL

7

4
3
4
2
pH

1
0

3
0

5

10

15

Time (hr)

20

25

30

Figure 17. Anaerobic growth of mixed cultures of S. typhimurium and L. johnsonii on the
glucooligosaccharide preparation at 37°C.
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Table 6. Growth comparison of chicken ceca bacteria on the glucooligosaccharide
preparations.
GOS,
Leuconostoc
glucooligosaccharide;
FOS,
Commercial
fructooligosaccharides (Samyang Genex Co., Seoul, Korea)
Relative growth to glucose as a carbon source at 24 hr incubation
Organism

([Absorbance unit of Glc at 24 hr/Absorbance unit of ×100]⋅hr-1)
glucose

GOS

FOS

100.00

22.77

61.20

C.B. # 2

100.00

99.34

79.29

C.B. # 3

100.00

75.85

48.01

C.B. # 4

100.00

36.72

61.40

C.B. # 5

100.00

87.23

50.25

C.B. # 6

100.00

87.17

87.66

C.B. # 1

a

Growth level at stationary phase (at 24 hr) on glucose was calculated as 100. C.B.; Ceca
Baterium
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Figure 18. Anaerobic growth of mixed cultures of S. typhimurium and ceca bacteria on the
glucooligosaccharide preparation at 37°C.
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the cecal bacterial isolates, #5 and #6, showed the same use pattern of GOS. Only the DP 3
polymer (panose) was utilized in the first 24 hours (Figure 19).
3. Possible Prebiotic Mechanism in Intestines
• α-glucosidase and GOS
The Leuconostoc GOS was found to inhibit the activity of α-glucosidase (maltase) (Figure
20). A double reciprocal plot indicated this was a non-competitive inhibition (Figure 21). In
order to determine the role of branching in the inhibition, the Ki values for panose and
isomaltotriose were determined. Only panose, containing α-1,4 and α-1,6 linkages, showed
an inhibition on α-glucosidase. Isomaltotriose, a linear glucose polymer linked by two α(1→6) linkages, was not inhibitory (Figure 22, 23).
• Growth test of B. longum and S. typhimurium with panose and maltodextrins
To determine whether a role for Leuconostoc GOS is as a starch metabolism inhibitor, B.
longum and S. typhimurium were grown in different combinations of panose and
maltooligosaccharides (from DP 4 to DP 10). As the concentration of panose increased, the
growth of S. typhimurium slowed but B. longum growth increased when panose was
supplied in the medium (Figure 24). A comparison of growth rates at log phase clearly
showed the growth inhibition of S. typhimurium by panose (Figure 25). In the case of B.
longum,

50%

panose

+

50%

maltooligosaccharides

and

75%

panose

maltooligosaccharides combinations showed better growth than other combinations.
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+25%
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Figure 19. TLC of anaerobic growth of chicken ceca bacterium # 5 on 0.5%
glucooligosaccharide preparations. Std, standard; Glc, glucose; IM3, isomaltotriose; IM5,
isomaltopentaose. The solvent system was a mixture of acetontrile, ethylacetate, propanol,
and water (in volume (mL) proportions of 85: 20: 50: 70). After development was complete,
the plates were dried and the carbohydrates visualized using a spray of an ethanol solution
containing 0.3 % (w/v) α-naphthol and 5 % (v/v) H2SO4.
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Figure 20. α-Glucosidase (maltase) activity inhibition with increasing concentrations of
Leuconostoc glucooligosaccharides. The assay was a linked assay system as described in
materials and methods.
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Figure 21. Double reciprocal plot of α-glucosidase (maltase) activity inhibition as the
concentration of the glucooligosaccharides increased.
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Figure 22. α-Glucosidase (maltase) activity in the presence of different concentrations of
panose (branched; α-1,4 and α-1,6) and isomaltotriose (linear; two α-1,6).
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Figure 23. Double reciprocal plot of α-glucosidase (maltase) activity change as the
concentration of panose or isomaltotriose increased.
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Figure 24. Anaerobic growth of S. typhimurium and B. longum on different combinations of
panose and maltooligosaccharides (d.p. 4 – 10) at 37°C.
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Figure 25. Comparison of growth rates in log phase between S. typhimurium and B.
longum at different concentrations of panose and maltooligosaccharides (M.O.).
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DISCUSSION
Technology for the production of oligosaccharides currently is limited to extraction from
plant sources, acid or enzymatic hydrolysis of polysaccharides or synthesis from starch
by transglycosylation reactions (Chesson, 1993; Morgan et al., 1992). These processes
are costly, limiting use of oligosaccharides to high value products. Conventional
fermentation is the simplest means for industrial manufacture of carbohydrate polymers.
Use of a chain shortening acceptor (Yoo, 1997) and a microbial strain that
produces primarily branched polymers in a dextran fermentation results in production of
branched α-glucooligosaccharides. High sucrose utilization in the early stages of the
fermentation fuels oligosaccharide production and cell growth. Some of the fructose,
liberated intracellularly by sucrose phosphorylase, probably is utilized by the cells,
accounting for the observed conversion efficiency of 71 %. Fructose that accumulates is
a byproduct of sucrose cleavage during synthesis of oligosaccharides. Dols et al. (1997)
proposed that L. mesenteroides possesses an efflux mechanism for fructose such that the
cell excretes fructose and then reassimilates the fructose via a phosphoenolpyruvate
(PEP)-dependent fructose phosphotransferase mechanism (Dominguez and Lindley,
1996). The accumulation of fructose has been observed in other Leuconostoc species.
(Dols et al., 1997; Dominguez and Lindley, 1996; Lawford et al., 1979; Tsuchiya et al.,
1952). As the sucrose is depleted, the accumulating fructose is metabolized and mannitol
is produced. Soetaert et al. (1995) studied mannitol production by Leuconostoc under
various batch and continuous culture conditions, with varying media compositions. They
concluded that low pH values and temperatures led to increases in conversion efficiency
and decreases in conversion rates. They also demonstrated that conversion efficiency
strongly depended on the (extracellular) fructose concentration. High fructose
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concentrations lead to nearly quantitative conversions, while low fructose concentrations
cause a conversion efficiencies to drop below 50%. (Soetaert et al., 1995).
Mannitol was a major end product in the Leuconostoc fermentation, but it is
necessary to separate mannitol from the oligosaccharides if they are to be used as
prebiotics, as mannitol can also be a carbon source for microorganisms. Most of the
mannitol (86.4 %) was recovered without further processing by crystallization at 4 °C.
To obtain highly purified oligosaccharides (> 98.8 %), a cation exchange column was
used. A Ca2+ resin has high ionic strength and divalent properties, which may account for
the increased resolution seen when it was used. On a Ca2+ resin, oligosaccharides eluted
first followed by a mixture of mannitol and organic acids (lactic acid and acetic acid).
The smaller mannitol molecule eluted after the oligosaccharides in part because of partial
ionization of the mannitol at the 6.5 pH. Divalent cations such as Ca2+ bind strongly to
the organic acids (Miller, 1989; Weaver and Plawecki, 1994). At pH 6.5, which is above
the pK value of lactic and acetic acids, they exist in dissociated forms. The stronger
organic acid that is lactic (pK of 3.79) eluted later because it interacts more strongly with
Ca2+ than acetic acid, pK value of 4.7.
The oligosaccharides produced were branched polymers between DP 2 and 7 in
size. The degree of polymerization (DP) for most prebiotic oligosaccharides falls in the
range of DP 2 to 8 (Loo et al., 1999). Those oligosaccharides larger than DP 3 were
branched, based on the Rf values and

13

C N.M.R analysis. Dextrans from L.

mesenteroides ATCC 13146 show a high degree of branching and exhibit a comblike
structure that is resistant to enzyme hydrolysis. The branches are single glucose
molecules in length (Cote and Robyt, 1983; Remaud et al., 1992). Oligosaccharides
synthesized by the dextransucrase from this bacterium had α-1,6 backbones with α-1,3,
and/or α-1,4-branched side chains when maltose was used as an acceptor (Remaud et al.,
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1992). However, it seems that the glucooligosaccharides produced in this study contain
mainly by α-1,4 and α-1,6 linkages and maltose is linked to the reducing end of the
isomaltosyl residues by judging the 13C n.m.r. data,.
An earlier study indicated that some pathogenic microorganisms did not grow
well on a L. mesenteroides ATCC 13146 preparation (Yoo, 1997). Based on this study,
the oligosaccharides produced from L. mesenteroides (ATCC 13146) were thought to be
applicable for enhancing growth of Bifidobacterium and Lactobacilli. It was expected
that ingestion of this preparation could bring the concomitant health effects associated
with enhanced Bifidobacterium populations.
When S. typhimurium or E. coli was grown on ATCC 13146 oligosaccharide
preparations, there was less than 37% of the equivalent growth on glucose, similar to
growth on commercial fructooligosaccharides (less than 35%). Lactobacillus johnsonii
and B. longum showed no differences in growth rate on glucose or the oligosaccharide
preparations. When L. johnsonii and S. typhimurium were grown together on
oligosaccharide preparations, the oligomers stimulated the growth of the Lactobacillus,
but were not readily utilized by the Salmonella. TLC showed clearly that the GOS
stimulated growth of Bifidobacterium but were not utilized readily by Salmonella and E.
coli. It appears that these oligosaccharides are utilized preferentially by some probiotic
strains.
The antagonistic role of probiotic strains to pathogens is attributed to competition
for available nutrients and/or attachment sites on intestinal epithelial cells and production
of antimicrobial compounds such as bacteriocins (Rolfe, 2000; Juven et al., 1991).
Lactobacilli have been extensively investigated for production of bacteriocins and
bacteriocin-like compounds. A limited number of studies have been carried out to
demonstrate production of antimicrobials or bacteriocins by the bifidobacterial strains
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(Faure et al., 1982; Anand et al., 1985; Meghrous et al., 1990; Bernet et al., 1993;
Gibson and Wang, 1994b; Oyarzabal and Conner, 1995; O’Riordan and Fitzgerald,1998).
The homofermentative Lactobacilli produce a number of bacteriocins, each with a
distinct spectrum of activity (DeKlerk, 1967; DeKlerk and Smit, 1967). For instance,
crude lactidin has inhibitory activity against numerous genera including Proteus spp.,
Salmonella spp., E. coli, and Staphylococcus spp. (Vincent et al.,1959). A proteinaceous
factor in a culture supernatant fluid of a B. longum strain interfers with
Enterobacteriaceae binding to GA1 receptor sites on the intestinal brush border
membrane (Fujiwara et al., 1997; O’Riordan and Fitzgerald, 1998). Other antagonists
that can be produced by probiotic bacteria are lactic and acetic acids (Tramer, 1966;
Sorrells and Speck, 1970) and hydrogen peroxide (Wheater et al., 1952; Whittenbury,
1964). Organic acids, such as acetic and lactic acid, will inhibit growth of many bacteria,
including pathogenic Gram-negative organisms (Burnett and Hanna, 1963; Sorrells and
Speck, 1970; Herrick, 1972; Ibrahim and Bezkorovainy, 1993). The undissociated forms
are the most bactericidal (Sorrells and Speck, 1970; Adams and Hall, 1988), because the
dissociation of the acid molecules following their entry into the cytoplasm reduces the
transmembrane proton gradient and neutralizes proton motive force; changing internal
pH’s, causing protein denaturation and viability loss (Ray, 1996). The inhibition of E.
coli by L. acidophilus has been shown (Tramer, 1966). Barnes et al. (1979) discovered
that if the pH was lower than about 5.5, Salmonella were unable to multiply.
To test the potential of this GOS as a prebiotic in poultry, six different microbial
strains were isolated from chicken ceca. These isolates were identified as lactic acid
bacteria by colonial morphology and chemical reaction (Gram positive, catalase negative,
and lactic acid formation from glucose, data not shown). When utilization of the
Leuconostoc glucooligosaccharides by these isolates was compared to utilization of a
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commercial fructooligosaccharide (FOS), three of the six isolates showed higher growth
after 24 hr on GOS than on FOS. In tests of mixed cultures of these lactic acid bacteria
and Salmonella on the glucooligosaccharides, five of the six cecal isolates showed higher
growth rates and inhibited growth of Salmonella. Similar results were seen with
Lactobacillus and Bifidobacterium strains. Two isolates showed identical patterns of
consumption of GOS. They only degraded the DP 3 component of the GOS mixture.
Similar effects have been seen in studies on the effect of fructooligosaccharides in feed
trials with broilers. FOS reduced susceptibility of poultry to Salmonella colonization
(Bailey et al., 1991), increased Bifidobacterium levels, and reduced the level of
Salmonella present in the caecum. Chamber et al. (1997) studied S. typhimurium
colonization in 3-, 5-, and 6- wk-old broilers fed either a control ration or rations with
added fructooligosaccharides (FOS) or lactose derivatives (LD). Both FOS and LD
reduced cecal pH and density. In addition, broilers fed refined FOS had a lower rate of
infection by S. typhimurium than control broilers.
The low pH produced by the chicken cecal bacteria is likely responsible for the
observed suppression of S. typhimurium growth in mixed cultures. Although other
antagonistic substances such as bacteroicins and hydrogen peroxide could be produced
that can inhibit S. typhimurium, significant levels of lactic acid bacteria must be
generated first. These studies do not directly predict in vivo effects but indicate that this
type of oligomers can be an avian prebiotic.
Although the ability of probiotic bacteria to ferment oligosaccharides may be an
especially important characteristic (Collins and Gibson, 1999; Crittenden, 1999; Gibson
and Roberfroid, 1995; Macfalane and Cummings, 1999; Roberfroid, 1998; Wang and
Gibson, 1993; Kaplan and Hutkins, 2000), there is no clear answer as to why prebiotics
stimulate growth of probiotic strains such as Lactobacilli and Bifidobacteria.
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Many genes are required for maltose regulation and the transport and processing
of maltodextrins in E. coli. For example, the LamB protein is required for binding and
transporting maltodextrins across the outer membrane. MalF, MalB, and MalK proteins
form a pore in the cytoplasmic or inner membrane that allows the MalE protein in the
periplasmic space to pass maltodextrin to the cytoplasm. In the cytoplasm, MalP
(maltodextrin phosphorylase; E.C. 2.4.1.1.) and MalQ (amylomaltase; E.C. 2.4.1.25)
degrade maltodextrins and maltose to glucose-1-phosphate and glucose, respectively.
These compounds act as energy and carbon sources, after conversion to glucose-6phosphate (Schwartz, 1987).
Because, the glucooligosaccharides produced by L. mesenteroides ATCC 13146
are linked by α-1,4 and α-1,6 linkages with maltose on the reducing end, it seemed
possible that these oligosaccharides might act as inhibitors of those enzymes needed for
maltose or maltodextrin utilization. α-Glucosidase, which cleaves maltose into two
glucose molecules, was chosen to test this hypothesis. L. mesenteroides ATCC 13146
oligosaccharides were found be a non-competitive inhibitor of α-glucosidase (maltase).
To verify inhibition of α-glucosidases by branched oligomers, panose and isomaltotriose
were tested for inhibition. Panose contains α-1,4 and α-1,6 linkages and is one of the
components in the Leuconostoc GOS. Panose inhibited α-glucosidase, whereas
isomaltotriose, containing two α-1,6 linkages in a linear structure, did not. Panose also
suppressed growth of S. typhimurium but not B. longum. B. longum showed increased
growth when panose and maltodextrins were supplied in the medium together compared
with maltodextrin alone. When growth rates at early log phase were compared, growth
inhibition of S. typhimurium by panose was clearly evident.
Adhesion of Bifidobacterium strains to native maize, potato, oat, and barley
starch granules has been examined (Crittenden et al., 2001). Interestingly, the α-1,481

linked glucose disaccharide, maltose, inhibited adhesion with the degree of inhibition
increasing with increasing starch polymer length. No effect was observed with a β-1,4linked disaccharide, cellobiose, or a α,α-1,1-linked disaccharide, trehalose. Of 28 strains
of lactic acid bacteria and bifidobacteria examined for their ability to ferment
fructooligosaccharides (FOS) on MRS agar, 12 of 16 Lactobacillus strains and 7 of 8
Bifidobacterium strains fermented FOS (Kaplan and Hutkins, 2000). Some strains of
bifidobacteria produce an extracellular dextranase, which hydrolyses dextran to a
mixture of isomaltotriose, isotetraose, isopentaose and higher isomaltodextrins (Rasic
and Kurmann, 1983). An intracellular enzyme, α-1,6 glucosidase (isomaltodextranase),
was found in extracts obtained from a rumen strain of Bifidobacterium that was cultured
on dextran (Bailey and Roberton, 1962; Rasic and Kurmann, 1983). Human strains of
bifidobacteria

metabolize

raffinose

(except

B.

bifidum),

lactulose,

and

N-

acetylglucosamine-containing saccharides present in human milk to acetic and lactic
acids. Lactulose is also metabolized by Enterococci and Lactobacilli (Rasic and
Kurmann, 1983).
Bearing this in mind, it seems that maltose and maltodextrins could inhibit the
adherence of Bifidobacterium to starch molecules in the intestine. Therefore, other
organisms would compete better in this situation. However, if prebiotic sugars are
introduced in the intestine, these sugars may inhibit the flow of starch or maltodextrin
utilization. Therefore, the utilization of the carbon source would be biased to the
probiotic strains, and then they outcompete other organisms. Healthy probiotic
populations can also produce antagonistic compounds such as organic acids and/or
bacteriocin. Chambers et al. (1997) studied Salmonella typhimurium colonization in 3-,
5-, and 6- wk-old broilers fed either a control ration or rations with added
fructooligosaccharides (FOS) or lactose derivatives (LD). They observed both FOS and
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LD reduced cecal pH and density. Broilers fed refined FOS had lower infections than
control broilers. However, the decline of Salmonella infections, decreased pH and cecal
density of broilers fed either refined FOS or LD disappeared within 1 week after
withdrawal of these carbohydrates. A human study of the administration of a milk
product containing Lactobacillus rhamnosus supported this postulate. In this study, the
composition of the fecal microflora of 10 healthy subjects was monitored before (6month control period), during (6-month test period), and after (3 month post test period)
the milk product. During the administration of the product containing Lactobacillus
rhamnosus, there was a predominace of L. rhamnosus, but the population disappeared in
most of the subjects after consumption of the product ceased (Tannock et al., 2000).
Oligosaccharides (branched or partially branched) most likely inhibit some of
those enzymes required for utilization of starch in other genera, such as Escherichia and
Salmonella. Panose and the Leuconostoc oligosaccharides reduced the activity of αglucosidase that degrades α-1,4 linkage in a maltose or maltodextrin. Panose alone did
not produce a higher growth rate than maltooligosaccharides and panose together for B.
longum. It is likely that high concentrations of panose also can inhibit enzymes seen in
maltooligosaccharide inhibition. There seems to be a synergistic effect for the probiotic
strains on carbon source utilization when maltodextrin and prebiotic sugars are present
together.
An examination of the expression levels of maltose operon and enzyme inhibition
tests in the presence and absence of prebiotic sugars would be justified to establish if a
relationship exists between the maltose operon and prebiotic sugars.
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APPENDIX A: 13C N.M.R. DATA
Assignment

Branched (d.p. 6) a

Maltose

Panose

C-1→ 4

100.7
100.6

100.7
100.6

100.7

C-1→ 3

100.15

C-1→ 6

98.87
98.65
98.55

C-1β

96.7

96.8

96.8

C-1α

92.8

92.9

92.9

C-3→ 1

81.4

C-4→ 1

78.5
78.2

78.2
78.0

78.6
78.3

C-3β b

77.07

77.2

77.2

C-5β b

75.4

75.5

75.6

C-2β b

74.9

75.1

75.1

C-6→ 1

66.9
66.25

99.06

66.9

61.8
61.9
61.7
61.6
61.8
61.6
61.6
61.4
61.3
a. Branched hexasaccharide(degree of polymerization; 6) produced by acceptor
reaction from L. mesenteroides NRRL ATCC 13146 (Adopted from Remaud et
al. 1992)
b. These chemical shifts correspond to the free carbon C-2β, C-3β, C-5β of the
glucose residue (β anomer) located at the reducing end.

C-6
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APPENDIX B: STRUCTURES OF OLIGOSACCHARIDES

galactooligosacchrides
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